Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
Open accessAbstract
Adipose, skeletal, and hepatic muscle tissues are the main endocrine organs that produce adipokines, myokines, and hepatokines. These biomarkers can be harmful or beneficial to an organism and still perform crosstalk, acting through the endocrine, paracrine, and autocrine pathways. This study aims to review the crosstalk between adipokines, myokines, and hepatokines. Far beyond understanding the actions of each biomarker alone, it is important to underline that these cytokines act together in the body, resulting in a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders and their respective outcomes, such as type 2 diabetes mellitus (DM2), obesity, metabolic syndrome, and cardiovascular diseases (CVD). Overweight individuals secrete more pro-inflammatory adipokines than those of a healthy weight, leading to an impaired immune response and greater susceptibility to inflammatory and infectious diseases. Myostatin is elevated in pro-inflammatory environments, sharing space with pro-inflammatory organokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), resistin, and chemerin. Fibroblast growth factor FGF21 acts as a beta-oxidation regulator and decreases lipogenesis in the liver. The crosstalk mentioned above can interfere with homeostatic disorders and can play a role as a potential therapeutic target that can assist in the methods of diagnosing metabolic syndrome and CVD.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review describes how adipokines, myokines, and hepatokines act through endocrine, paracrine, and autocrine crosstalk to influence insulin resistance, obesity, metabolic syndrome, and cardiovascular disease. It argues these organokines may serve as diagnostic/prognostic biomarkers and therapeutic targets, while calling for more in vivo and mechanistic studies.
Key findings
- Adipose, skeletal muscle, and liver are the main endocrine organs producing adipokines, myokines, and hepatokines; these biomarkers can be harmful or beneficial and act together in a complex network affecting DM2, obesity, metabolic syndrome, and CVD.
- Overweight individuals secrete more pro-inflammatory adipokines, leading to impaired immune response and greater susceptibility to inflammatory and infectious diseases; myostatin is elevated in pro-inflammatory environments alongside TNF-α, IL-1, resistin, and chemerin.
- FGF21 acts as a beta-oxidation regulator and decreases lipogenesis in the liver; exercise shifts secretion toward anti-inflammatory organokines such as irisin, IL-6, IL-15, myonectin, adiponectin, and FGF21, which mitigate harmful effects of myostatin, TNF-α, resistin, chemerin, and fetuin-A.
- The introduction cites an estimated 1.7 billion people vulnerable to health risks determined by body weight, 2.5 million deaths annually related to increased BMI expected to double by 2030, and CVDs responsible for approximately 17.9 million deaths per year, corresponding to 31% of total deaths worldwide.
Methods
- Descriptive review using PUBMED-Medline, Embase, and Cochrane databases.
- Mesh terms were adipokines, myokines, hepatokines, abdominal fat, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases.
- Inclusion/exclusion was based on studies that included crosstalk among organokines, not just individual assessment of each one on insulin resistance, diabetes, obesity, metabolic syndrome, and cardiovascular complications.
Limitations
- The paper states that in vivo experimental studies are further needed addressing crosstalk between adipokines, myokines, and hepatokines to support future clinical treatments, and that biochemical mechanisms of action of organokines are needed to guide future clinical trials.
- Evident from the text: this is a descriptive/narrative review without a systematic protocol, risk-of-bias assessment, or quantitative synthesis; the search strategy and study selection are reported only briefly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 222 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Elevated leptin levels are associated with development, progression, and prognostication of non-alcoholic fatty liver disease.
“Elevated levels of leptin were associated with development, progression and prognostication of non-alcoholic fatty liver disease (NAFLD) [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Polyzos, 2016, Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis, Diabetology source
Not checked in the free run.
- Premisecitation
In adults with hyperleptinemia and leptin resistance, administration of metreleptin showed marginal benefits with a reduction in glycated hemoglobin.
“In adults with hyperleptinemia and leptin resistance administration of metreleptin showed marginal benefits with a reduction in glycated hemoglobin [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Moon, 2011, Efficacy of metreleptin in obese patients with type 2 diabetes: Cellular and molecular pathways underlying leptin tolerance, Diabetes source
Not checked in the free run.
- Premisecitation
Leptin is released by subcutaneous white adipose tissue.
“Leptin is released by subcutaneous white adipose tissue (WAT) [39]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Scheja, 2019, The endocrine function of adipose tissues in health and cardiometabolic disease, Nat. Rev. Endocrinol. source
Not checked in the free run.
- Premisecitation
Organokines have specific associations with insulin resistance, diabetes mellitus, obesity, metabolic syndrome, and cardiovascular disease.
“Therefore, they have specific associations with insulin resistance, diabetes mellitus, obesity, metabolic syndrome, and CVD [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Faramia, 2020, Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines, Curr. Opin. Pharmacol. source
Not checked in the free run.
- Rests on an assumption: Adipose, skeletal muscle, and hepatic tissues are the main endocrine organs that produce adipokines, myokines, and hepatokines.
- Rests on an assumption: These biomarkers can be harmful or beneficial and perform crosstalk through endocrine, paracrine, and autocrine pathways.
- Premisecitation
Hyperleptinemia contributes to the action of pro-inflammatory cytokines and continuous infiltration of M1 macrophages.
“Hyperleptinemia contributes to the action of pro-inflammatory cytokines and continuous infiltration of M1 macrophages [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Excess weight combined with hyperglycemia predisposes to oxidative stress and inflammation.
“The excess weight combined with hyperglycemia predisposes oxidative stress and inflammation [2]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Sofra, 2020, Adverse effects of sedentary lifestyles: Inflammation, and high-glucose induced oxidative stress—A double blind randomized clinical trial on diabetic and prediabetic patients, Health source
Not checked in the free run.
- Premisecitation
High levels of LCN2 are associated with cardiovascular disease, vascular remodeling, and instability of atherosclerotic plaques by regulating MMP-9.
“High levels of LCN2 are associated with CVD, vascular remodeling, and instability of atherosclerotic plaques by regulating the metalloproteinase activity (MMP-9) [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Cakirca, 2018, Serum matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9/ neutrophil gelatinase-associated lipocalin complex levels in patients with early-stage diabetic nephropathy, Iran. J. Kidney Dis.
Not checked in the free run.
- Premisenone given
LCN2/NGAL is a glycoprotein identified as a cytokine of adipose tissue present in low-level systemic inflammation in obese patients with metabolic syndrome.
“Lipocalin 2 (LCN2), also associated with neutrophil gelatinase-associated lipocalin (NGAL), is a glycoprotein identified as the cytokine of adipose tissue present in low-level systemic inflammation in obese patients with metabolic syndrome.”
Quote in the paperNot a substantial claim - Interpretationcitation
Inhibition of adipogenesis can restrict storage of triglycerides in adipose tissue, increasing circulating levels (systemic hyperlipidemia) and lipid deposition in liver and skeletal muscle.
“Therefore, the inhibition of adipogenesis can restrict the storage of triglycerides in tissue adipose, increasing circulating levels (systemic hyperlipidemia) and lipid deposition in the liver and skeletal muscle [55].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Fu, 2018, Circulating osteonectin and adipokine profiles in relation to metabolically healthy obesity in Chinese children: Findings from BCAMS, J. Am. Heart Assoc. source
Not checked in the free run.
- Interpretationcitation
Protective actions of asprosin can be associated with its functions of enhancing mitochondrial respiration under hypoxia.
“These protective actions of asprosin can be associated to its functions of enhancing mitochondrial respiration under hypoxia [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Wen, M.S., Wang, C.Y., Yeh, J.K., Chen, C.C., Tsai, M.L., Ho, M.Y., Hung, K.C., and Hsieh, I.C. (2020). The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc. Dis., 20. source
Not checked in the free run.
- Premisecitation
SPARC/BM40/osteonectin modulates expression of pro-inflammatory cytokines involved in insulin resistance and adipogenesis.
“The secreted acidic protein rich in cysteine (SPARC), known as BM40 or osteonectin, modulates the expression of pro-inflammatory cytokines involved in insulin resistance and adipogenesis [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Recinella, 2020, Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases, Front. Physiol. source
Not checked in the free run.
- Premisecitation
Vaspin protects vascular tissues from fatty acid-induced apoptosis via PI3K/Akt/eNOS signaling pathway.
“Studies show that vaspin protects vascular tissues from fatty acid-induced apoptosis via the signaling pathway PI3K/Akt/eNOS [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Zieger, 2018, Vaspin suppresses cytokine-induced inflammation in 3T3-L1 adipocytes via inhibition of NFκB pathway, Mol. Cell. Endocrinol. source
Not checked in the free run.
- Premisenone given
In humans, resistin is produced by macrophages and monocytes infiltrated in adipose tissue.
“In humans, it is produced by macrophages and monocytes infiltrated in adipose tissue.”
Quote in the paperNot a substantial claim - Premisenone given
FGF21 expression in white and brown adipose tissue is caused by exposure to cold or physical exercise.
“Another substance recently introduced as an adipokine is fibroblast growth factor 21 (FGF21), whose exposure to cold or physical exercise causes its expression in white and BAT.”
Quote in the paperNot a substantial claim - Premisecitation
LCN2 receptors megalin/GP330 and SLC22A17 or 24p3R are involved in regulating inflammation and transport of fatty acids and iron.
“Its receptors, the megalin/glycoprotein GP330 and SLC22A17 or 24p3R, the solute carrier family 22 members 17 binding mouse LCN2, are involved in regulating inflammation and the transport of fatty acids and iron [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Recinella, 2020, Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases, Front. Physiol. source
Not checked in the free run.
- Premisecitation
AdipoRon, an orally active synthetic adiponectin receptor agonist, improved vascular function in mesenteric arteries independently of endothelium mechanism in mice.
“Recently, an orally active synthetic adiponectin receptor agonist, AdipoRon, was developed and studied in an experimental animal study (mice) showing improvement in vascular function in the mesenteric arteries independently of endothelium-mechanism [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Choi, S.-K., Kwon, Y., Byeon, S., Haam, C.E., and Lee, Y.-H. (2020). AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice. PLoS ONE, 15. source
Not checked in the free run.
- Interpretationcitation
Asprosin can be an important biomarker for predicting the development of diabetes.
“For these reasons, asprosin can be an important biomarker for predicting the development of diabetes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Gozel, N., and Kilinc, F. (2020). Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol. Polska. source
Not checked in the free run.
- Premisenone given
SFRP5 is expressed in white adipose tissue in higher amounts compared to other tissues.
“The secreted frizzled-related protein 5 (SFRP5), recently identified as an adipokine, is expressed in WAT in higher amounts compared to other tissues.”
Quote in the paperNot a substantial claim - Premisecitation
Asprosin levels are elevated in comorbidities such as obesity and type 2 diabetes mellitus.
“Asprosin levels are elevated in comorbidities such as obesity and DM2.”
Quote in the paperNot a substantial claim - Premisenone given
In glucose metabolism, resistin is related to activating SOCS3, an inhibitor of insulin signaling.
“In glucose metabolism, resistin is related to activating an inhibitor of insulin signaling, the suppressor of cytokine signaling 3 (SOCS3).”
Quote in the paperNot a substantial claim - Premisecitation
Vaspin can suppress vascular cell proliferation and migration by reducing JNK and ERK1/2 pathways and increasing collagen via PI3K/Akt pathways.
“It can also suppress vascular cell proliferation and migration by reducing the c-Jun N-terminal kinase (JNK) and ERK1/2 pathways and increasing collagen via the PI3K/Akt pathways [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Sato, K., Shirai, R., Yamaguchi, M., Yamashita, T., Shibata, K., Okano, T., Mori, Y., Matsuyama, T.A., Ishibashi-Ueda, H., and Hirano, T. (2018). Anti-atherogenic effects of vaspin on human aortic smooth muscle cell/macrophage responses and hyperlipidemic mouse plaque phenotype. Int. J. Mol. Sci., 19. source
Not checked in the free run.
- Premisecitation
SPARC inhibits the initial stage of adipogenesis by inhibiting mitotic clonal expansion of pre-adipocytes.
“Its function is related to the inhibition in the initial stage of adipogenesis through inhibiting the mitotic clonal expansion of pre-adipocytes [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Mukherjee, 2020, Secreted protein acidic and rich in cysteine (SPARC) regulates thermogenesis in white and brown adipocytes, Mol. Cell. Endocrinol. source
Not checked in the free run.
- Premisecitation
FAM19A5 inhibits vascular smooth muscle cell proliferation and inflammation related to cardiovascular disease through obesity.
“Studies demonstrate that FAM19A5 inhibits vascular smooth muscle cell proliferation and inflammation related to cardiovascular disease through obesity [29].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Zarzour, 2018, Understanding obesity-related cardiovascular disease: It’s all about balance, Circulation source
Not checked in the free run.
- Premisecitation
Decrease in plasma apelin is commonly observed in the elderly due to reduction in muscle mass.
“The decrease in plasma apelin is commonly observed in the elderly due to the reduction in muscle mass.”
Quote in the paperNot a substantial claim - Premisenone given
Irisin is a cleavage product of type III transmembrane fibronectin protein containing domain 5 (FNDC5), released after cleavage of the carboxy group.
“Irisin, one of the most recent myokines identified, is a cleavage product of type III transmembrane fibronectin protein containing domain 5 (FNDC5), released after cleavage of the carboxy group.”
Quote in the paperNot a substantial claim - Interpretationreasoning
FGF21 has great therapeutic potential in several metabolic comorbidities such as obesity, type 2 diabetes mellitus, and metabolic syndrome.
“It has great therapeutic potential in several metabolic comorbidities, such as obesity, DM2, and metabolic syndrome.”
Quote in the paperSubstantial claim - Premisenone given
Unlike most myokines, exercise seems to decrease myostatin expression.
“Unlike most myokines, exercise seems to decrease myostatin expression.”
Quote in the paperNot a substantial claim - Premisecitation
IL-6 stimulates insulin release by increasing expression of GLP-1.
“It also stimulates insulin release by increasing the expression of the glucagon-1-like peptide (GLP-1) [11,59].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- cites [59] Chung, 2020, Organokines in disease, Adv. Clin. Chem. source
Not checked in the free run.
- Premisecitation
Elevated levels of FGF21 after exercise reveal crucial functions for glucose and lipid metabolism.
“Elevated levels of FGF21 after exercise reveal crucial functions for glucose and lipid metabolism.”
Quote in the paperSubstantial claim - Premisecitation
Fet-A levels are increased in obese individuals with diabetes.
“Fet-A levels are increased in obese individuals with diabetes [35].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Khadir, 2020, Fetuin-a expression profile in mouse and human adipose tissue, Lip. Health Dis. source
Not checked in the free run.
- Premisecitation
Apelin is pointed out as a biomarker of early sarcopenia.
“Therefore, this myokine is also pointed out as a biomarker of early sarcopenia [58].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Kwon, J.H., Moon, K.M., and Min, K.W. (2020). Exercise-induced myokines can explain the importance of physical activity in the elderly: An overview. Healthcare, 8. source
Not checked in the free run.
- Premisenone given
Myostatin exhibits negative consequences when increased, acting as a facilitator of muscle mass loss, either by inhibiting factors that promote tissue growth or by stimulating degradation mechanisms.
“Myostatin exhibits negative consequences when it is at increased levels, as it acts as a facilitator of muscle mass loss, either by inhibiting factors that promote tissue growth or by stimulating degradation mechanisms.”
Quote in the paperNot a substantial claim - Premisecitation
Serum ZAG levels are lower in overweight or obese patients.
“Studies show that serum ZAG levels are lower in overweight or obese patients [37].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Wang, 2020, Low serum ZAG levels correlate with determinants of the metabolic syndrome in Chinese subjects, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
Experimental studies of visceral obesity found WISP1 can induce mesenchymal stem cell proliferation and consequently expansion of adipose tissue.
“Experimental studies of visceral obesity have found that WISP1 can induce mesenchymal stem cells’ proliferation and, consequently, the expansion of tissue adipose [30].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Barchetta, 2017, WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes, J. Endocr. Soc. source
Not checked in the free run.
- Premisecitation
METRNL reduces fat mass.
“This myokine has been shown to contribute to the browning of WAT and, consequently, to greater energy expenditure through the oxidation of glucose and FFA and reduction in fat mass [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
In mice, overexpression of activin E raises thermogenesis and insulin sensitivity by stimulating brown adipocytes in BAT.
“A study in mice showed that activin E has several functions: initially, it is needed to induce thermogenesis by stimulating beige adipocytes in WAT; then, its overexpression raises thermogenesis and insulin sensitivity by stimulating activity of brown adipocytes in BAT; finally, activin E is closely related to FGF21 in WAT, which may increase its expression in brown pre-adipocyte culture.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Hashimoto, 2018, Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine, Cell Rep. source
Not checked in the free run.
- Interpretationcitation
Adropin affects the progression of vascular atherosclerosis.
“Thus, it ended up providing evidence that adropin affected the progression of vascular atherosclerosis [81].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Zhao, 2015, Serum adropin level in patients with stable coronary artery disease, Heart Lung Circulat. source
Not checked in the free run.
- Premisecitation
In mice, activin E is needed to induce thermogenesis by stimulating beige adipocytes in WAT.
“A study in mice showed that activin E has several functions: initially, it is needed to induce thermogenesis by stimulating beige adipocytes in WAT; then, its overexpression raises thermogenesis and insulin sensitivity by stimulating activity of brown adipocytes in BAT; finally, activin E is closely related to FGF21 in WAT, which may increase its expression in brown pre-adipocyte culture.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Hashimoto, 2018, Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine, Cell Rep. source
Not checked in the free run.
- Premisecitation
METRNL increases the expression of M2 macrophages in adipose tissue.
“METRNL also shows an anti-inflammatory role, especially in reducing adipose inflammation, increasing the expression of M2 macrophages in adipose tissue, and improving insulin resistance typical of obesity [62].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Gholamrezayi, 2020, Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines, Lip. Health Dis. source
Not checked in the free run.
- Premisecitation
Adropin is a biomarker of cardiovascular dysfunction.
“Still, in this respect, there is increasing evidence that adropin is a biomarker of cardiovascular dysfunction, initially because in vitro tests showed that endothelial cells treated with adropin had greater proliferation, migration, formation of a capillary-like tube, and positive regulation of the expression of nitric oxide endothelial synthase (eNOS).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Zhao, 2015, Serum adropin level in patients with stable coronary artery disease, Heart Lung Circulat. source
Not checked in the free run.
- Premisereasoning
Low adropin levels are observed in people with obesity, polycystic ovary syndrome, fatty liver, insulin resistance, and cardiovascular disease (CVD).
“As a result, these low levels are observed in people with obesity, polycystic ovary syndrome, fatty liver, insulin resistance, and CVD, suggesting that low levels of adropin are closely associated with metabolic disorders.”
Quote in the paperSubstantial claim - Premisecitation
A decrease in fetuin-A levels by physical activity can reduce visceral adipose tissue via a reduction in available FFA.
“On the other hand, the decrease in fetuin-A levels by physical activity can show a beneficial potential by reducing visceral adipose tissue via a reduction in the available FFA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Fetuin-A can develop injury to pancreatic β cells, which are responsible for insulin production.
“Fetuin-A performs deleterious functions in these metabolic diseases precisely because it can develop injury to pancreatic β cells, which are responsible for insulin production [65].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Shen, 2015, Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity, Mol. Cell. Endocrinol. source
Not checked in the free run.
- Premisecitation
Weight loss increased levels of adropin in patients who underwent bariatric surgery.
“A study of patients who underwent bariatric surgery showed that weight loss increased levels of adropin [80].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Rogala, 2019, Serum irisin, adropin, and preptin in obese patients 6 months after bariatric surgery, Obesity Surg. source
Not checked in the free run.
- Premisecitation
Decorin is secreted by skeletal muscle cells.
“It is secreted by skeletal muscle cells and is involved in the skeletal muscle hypertrophy and regulates muscle growth with the practice of physical exercise [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., and Guzik, P. (2021). Effect of various exercise regimens on selected Exercise-induced cytokines in healthy people. Int. J. Environ. Res. Public Health, 18. source
Not checked in the free run.
- Premisecitation
Meteorin-like protein (METRNL) is positively regulated after resistance exercises.
“Meteorin-like protein (METRNL) is also positively regulated after resistance exercises, performing a series of beneficial actions for the metabolism of different tissues.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Decorin regulates muscle growth with the practice of physical exercise.
“It is secreted by skeletal muscle cells and is involved in the skeletal muscle hypertrophy and regulates muscle growth with the practice of physical exercise [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., and Guzik, P. (2021). Effect of various exercise regimens on selected Exercise-induced cytokines in healthy people. Int. J. Environ. Res. Public Health, 18. source
Not checked in the free run.
- Premisecitation
Steatosis is more closely related to the development of insulin resistance than obesity itself.
“In humans, plasma levels of fetuin-B are elevated in obese people with fatty liver and DM2, and studies have shown that steatosis is more closely related to the development of insulin resistance than obesity itself.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Ruth, 2015, Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism, Cell Metab. source
Not checked in the free run.
- Premisecitation
Fetuin-B decreases insulin sensitivity in muscle and hepatocytes in culture when administered at physiological concentrations.
“Indeed, it has been shown that fetuin-B decreases insulin sensitivity in muscle and hepatocytes in culture when administered to them in physiological concentrations, and, in this situation, it was not able to activate pro-inflammatory signaling [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Ruth, 2015, Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism, Cell Metab. source
Not checked in the free run.
- Premisecitation
Hepatokine regulation occurs via autocrine, paracrine, and endocrine actions in the liver and other tissues.
“Such situations are regulated via autocrine, paracrine, and endocrine both in the liver and other tissues [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
METRNL contributes to the browning of white adipose tissue (WAT).
“This myokine has been shown to contribute to the browning of WAT and, consequently, to greater energy expenditure through the oxidation of glucose and FFA and reduction in fat mass [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Fetuin B can promote insulin resistance in myotubes and hepatocytes.
“Thus, fetuin B can promote insulin resistance in myotubes and hepatocytes [18].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
A reduction in fetuin-A levels can control the accumulation of visceral adipose tissue by decreasing the activation of macrophage 1.
“Thus, it is still noteworthy that the reduction in fetuin-A levels can control the accumulation of visceral adipose tissue by decreasing the activation of macrophage 1, which has a pro-inflammatory action [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
In patients undergoing coronary artery bypass graft surgery, the lowest level of plasma adropin was associated with late saphenous vein graft occlusion.
“A recent study of patients undergoing coronary artery bypass graft surgery showed that the lowest level of plasma adropin was associated with late saphenous vein graft occlusion.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Zhao, 2015, Serum adropin level in patients with stable coronary artery disease, Heart Lung Circulat. source
Not checked in the free run.
- Premisenone given
Adropin concentrations are immediately regulated by the energy status and nutritional content of the diet.
“Adropin is a small peptide whose concentrations are immediately regulated by the energy status and nutritional content of the diet.”
Quote in the paperNot a substantial claim - Premisecitation
Hepatokines have greater interference in fatty and striated skeletal muscle tissue, acting through crosstalk with cytokines released by these tissues.
“Even so, there is a greater interference of hepatokines in the fatty and striated skeletal muscle tissue, showing an endocrine-dependent relationship, therefore acting through crosstalk with the cytokines released by these respective tissues [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- Premisecitation
In mice, overexpression of adropin increases fatty acid oxidation throughout the body.
“On the other hand, it has been seen that in mice, the overexpression of adropin reduces weight gain, attenuates hepatosteatosis, increases fatty acid oxidation throughout the body, improves insulin sensitivity, and improves glucose tolerance [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
- Premisecitation
METRNL increases energy expenditure through the oxidation of glucose and free fatty acids (FFA).
“This myokine has been shown to contribute to the browning of WAT and, consequently, to greater energy expenditure through the oxidation of glucose and FFA and reduction in fat mass [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Fetuin B acts by inhibiting the tyrosine kinase insulin receptor.
“Like fetuin-A, fetuin B is the second member of the fetuin family, produced primarily by the liver and acts by inhibiting the tyrosine kinase insulin receptor.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
METRNL has an anti-inflammatory role, especially in reducing adipose inflammation.
“METRNL also shows an anti-inflammatory role, especially in reducing adipose inflammation, increasing the expression of M2 macrophages in adipose tissue, and improving insulin resistance typical of obesity [62].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Gholamrezayi, 2020, Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines, Lip. Health Dis. source
Not checked in the free run.
- Premisecitation
METRNL improves the insulin resistance typical of obesity.
“METRNL also shows an anti-inflammatory role, especially in reducing adipose inflammation, increasing the expression of M2 macrophages in adipose tissue, and improving insulin resistance typical of obesity [62].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Gholamrezayi, 2020, Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines, Lip. Health Dis. source
Not checked in the free run.
- Premisecitation
In humans, plasma levels of fetuin-B are elevated in obese people with fatty liver and type 2 diabetes mellitus (DM2).
“In humans, plasma levels of fetuin-B are elevated in obese people with fatty liver and DM2, and studies have shown that steatosis is more closely related to the development of insulin resistance than obesity itself.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Ruth, 2015, Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism, Cell Metab. source
Not checked in the free run.
- Interpretationcitation
Seleno-protein plays a deleterious role when at high levels in patients with pre-diabetes and DM2, causing insulin resistance and hyperglycemia.
“Therefore, this liver cytokine plays a deleterious role when at high levels in patients with pre-diabetes and DM2, causing insulin resistance and hyperglycemia [73].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Misu, 2017, Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle, Nat. Med. source
Not checked in the free run.
- Premisecitation
In rats, monkeys, and humans, FGF21 moderates simple sugar intake and preferences for sweet foods via signaling with FGF21 receptors in the paraventricular nucleus of the hypothalamus.
“Beyond that, studies in rats, monkeys, and humans have shown that FGF21 moderates simple sugar intake and preferences for sweet foods via signaling with FGF21 receptors in the paraventricular nucleus of the hypothalamus and correlates with decreased dopamine neurotransmission within the nucleus accumbens [84].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Pedersen, 2019, Physical activity and muscle-brain crosstalk, Nat. Rev. Endocrinol. source
Not checked in the free run.
- Premisecitation
The Paigen diet is associated with NAFLD due to its high cholesterol content, which promotes liver chemerin expression.
“It has been found that the Paigen diet is associated with nonalcoholic fatty liver disease due to the high cholesterol content that promotes liver chemerin expression.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- Premisecitation
Obese rats submitted to a diet-induced weight cycling demonstrated a high hepatic production of LECT2.
“Obese rats submitted to a diet-induced weight cycling demonstrated a high hepatic production of LECT2 [87].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Chikamoto, 2016, Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice, Biochem. Biophys. Res. Commun. source
Not checked in the free run.
- Premisecitation
Low serum level of sex hormone-binding globulin (SHBG) is associated with nonalcoholic fatty liver disease (NAFLD) in post-menopausal women.
“At first, an association of this pathology with a low serum level of SHBG was found in post-menopausal women with NAFLD [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Lebensztejn, 2016, Hepatokines and non-alcoholic fatty liver disease, Acta Biochim. Polonica source
Not checked in the free run.
- Premisecitation
In humans, serum levels of hepassocin are elevated in pre-diabetes, DM2, and NAFLD.
“However, it has been shown that in humans, serum levels of hepassocin are elevated in pre-diabetes, DM2, and NAFLD because of their association with impaired fasting glucose, glucose intolerance, and insulin resistance [77].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Wu, 2016, A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes, Diabetologia source
Not checked in the free run.
- Premisecitation
An increase in serum ANGPTL4 may be related to insulin resistance in patients with metabolic syndrome compared to normal patients.
“However, the increase in serum ANGPTL4 may be related to insulin resistance in patients with metabolic syndrome compared to normal patients [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Lebensztejn, 2016, Hepatokines and non-alcoholic fatty liver disease, Acta Biochim. Polonica source
Not checked in the free run.
- Premisecitation
FGF21 decreases the production of glucose.
“Initially, it acts on insulin sensitization, increases the oxidation of fatty acids in the liver, decreases the production of glucose, increases the turnover of FFA, and reduces the development of steatohepatitis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
FGF21 increases the oxidation of fatty acids in the liver.
“Initially, it acts on insulin sensitization, increases the oxidation of fatty acids in the liver, decreases the production of glucose, increases the turnover of FFA, and reduces the development of steatohepatitis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
FGF21 increases the expression and production of adiponectin.
“As suggested previously, in the adipose tissue, FGF21 decreases lipolysis in vivo and in vitro, incites glucose retention in human adipocytes by inducing the expression of GLUT1 (which in fact improves insulin sensitivity in adipose tissue), increases expression and production of adiponectin, and “darkens” the white adipose tissue, turning it into brown.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisenone given
Patients with obesity-related insulin resistance show an increase in the basal levels of follistatin.
“Patients with obesity-related to insulin resistance show an increase in the basal levels of follistatin.”
Quote in the paperNot a substantial claim - Premisecitation
FGF21 "darkens" white adipose tissue, turning it into brown.
“As suggested previously, in the adipose tissue, FGF21 decreases lipolysis in vivo and in vitro, incites glucose retention in human adipocytes by inducing the expression of GLUT1 (which in fact improves insulin sensitivity in adipose tissue), increases expression and production of adiponectin, and “darkens” the white adipose tissue, turning it into brown.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
FGF21 incites glucose retention in human adipocytes by inducing the expression of GLUT1.
“As suggested previously, in the adipose tissue, FGF21 decreases lipolysis in vivo and in vitro, incites glucose retention in human adipocytes by inducing the expression of GLUT1 (which in fact improves insulin sensitivity in adipose tissue), increases expression and production of adiponectin, and “darkens” the white adipose tissue, turning it into brown.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
High levels of chemerin are detected in obesity, metabolic syndrome, insulin resistance, and dyslipidemia.
“High levels of chemerin are detected in obesity, metabolic syndrome, insulin resistance, and dyslipidemia [72].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] Pohl, 2017, Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis, Eur. J. Clin. Investig. source
Not checked in the free run.
- Premisecitation
ANGPTL4 is released by the liver into the circulation, especially during physical exercise because of the increased glucagon/insulin ratio.
“Angiopoietin-like 4 (ANGPTL4) is released by the liver into the circulation, especially during physical exercise because of the increased glucagon/insulin ratio, and it inhibits pancreatic lipases, which consequently decreases the absorption of fats [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
ANGPTL4 inhibits pancreatic lipases, decreasing the absorption of fats.
“Angiopoietin-like 4 (ANGPTL4) is released by the liver into the circulation, especially during physical exercise because of the increased glucagon/insulin ratio, and it inhibits pancreatic lipases, which consequently decreases the absorption of fats [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisenone given
Low concentration of SHBG is identified in DM2 and obese patients.
“Furthermore, this low concentration has also been identified in DM2 and obese patients.”
Quote in the paperNot a substantial claim - Premisecitation
FGF21 acts on insulin sensitization.
“Initially, it acts on insulin sensitization, increases the oxidation of fatty acids in the liver, decreases the production of glucose, increases the turnover of FFA, and reduces the development of steatohepatitis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
Seleno-protein influences the drop in concentrations of irisin, METRNL, and β-aminoisobutyric acid (BAIBA).
“When seleno-protein is found in high serum levels, it is associated with metabolic diseases, insulin resistance, and increased ROS via the activation of AMPK, and it influences the drop in concentrations of irisin, meteorin-like (METRNL), and β-aminoisobutyric acid (BAIBA), which consequently attenuates the loss of fat mass induced by physical exercises [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Intermittent hypoxia generates stress that increases the levels of seleno-protein P in human hepatocytes.
“In addition, studies have shown that intermittent hypoxia generates stress that increases the levels of seleno-protein P in human hepatocytes, increasing insulin resistance, accumulating fat in adipose tissue, and aggravating risks of developing atherosclerosis [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
- Interpretationcitation
Activin E may be a therapeutic target for obesity.
“It is inferred that activin E may be a therapeutic target for obesity [68].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Hashimoto, 2018, Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine, Cell Rep. source
Not checked in the free run.
- Premisecitation
Follistatin contributes to skeletal muscle fiber hypertrophy due to its affinity for myostatin, neutralizing it and increasing skeletal muscle mass.
“Follistatin is able to contribute to skeletal muscle fiber hypertrophy due to its affinity for myostatin, neutralizing it and increasing skeletal muscle mass, and inducing the expression of thermogenic genes in murine adipocytes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Interpretationcitation
After exercise, an increase in follistatin levels is beneficial because it favors successive glucose uptake by skeletal muscle tissue.
“However, after exercise, the increase in follistatin levels is beneficial since it favors successive glucose uptake by skeletal muscle tissue [83].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Weigert, 2019, Hepatokines—A novel group of exercise factors, Eur. J. Physiol. source
Not checked in the free run.
- Premisecitation
Adiponectin increases the production of SHBG by activating AMPK and reducing the activity of enzymes involved in liver lipogenesis.
“It was recently found that adiponectin increases the production of SHBG by activating AMPK and reducing the activity of enzymes involved in liver lipogenesis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Selva, 2015, Novel insights in SHBG regulation and clinical implications, Trends Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
FGF21 reduces the development of steatohepatitis.
“Initially, it acts on insulin sensitization, increases the oxidation of fatty acids in the liver, decreases the production of glucose, increases the turnover of FFA, and reduces the development of steatohepatitis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
Chemerin hyperexpression is found in patients with NAFLD and nonalcoholic steatohepatitis (NASH).
“That is, chemerin hyperexpression is found in patients with NAFLD and nonalcoholic steatohepatitis [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- Premisecitation
In adipose tissue, FGF21 decreases lipolysis in vivo and in vitro.
“As suggested previously, in the adipose tissue, FGF21 decreases lipolysis in vivo and in vitro, incites glucose retention in human adipocytes by inducing the expression of GLUT1 (which in fact improves insulin sensitivity in adipose tissue), increases expression and production of adiponectin, and “darkens” the white adipose tissue, turning it into brown.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- Premisecitation
Deletion of LECT2 increases insulin sensitivity in skeletal muscle in rats.
“Therefore, LECT2 can be an important marker to explain how the fatty liver leads to insulin resistance in obesity since its deletion of LECT2 increases insulin sensitivity in skeletal muscle in rats [67].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
- Interpretationcitation
Adipokines, myokines, and hepatokines act together in the body, forming a complex network of actions in different tissues.
“Far beyond understanding each adipokine, myokine, or hepatokine’s actions alone, it is important to underline that these cytokines act together in the body, forming a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders, and their respective outcomes, such as DM2, obesity, metabolic syndrome, and CVD”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Faramia, 2020, Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines, Curr. Opin. Pharmacol. source
Not checked in the free run.
- Premisecitation
Adipo-myokines IL-6 and TNF-α, secreted from muscle cells and adipocytes, if chronically elevated, can induce insulin resistance and consequently other comorbidities.
“Adipo-myokines, such as IL-6 and TNF-α, secreted from muscle cells and adipocytes, if chronically elevated, can induce insulin resistance and consequently other comorbidities [92].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Li, 2017, Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue, Cytokine Growth Factor Rev. source
Not checked in the free run.
- Premisecitation
These anti-inflammatory cytokines mitigate the harmful effects of myostatin, TNF-α, resistin, chemerin, fetuin-A, and other cytokines.
“For these reasons, physical exercise is a powerful ally in the prevention and improvement of the prognosis of cardiovascular diseases, DM2, and obesity, since it influences the predominance of the secretion of anti-inflammatory myokines, adipokines, and hepatokines, such as irisin, IL-6, IL -15, myonectin, adiponectin, FGF21 (which mitigate the harmful effects of myostatin), TNF-α, resistin, cheme”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Chen, 2020, Myokines mediate the cross talk between skeletal muscle and other organs, J. Cell. Physiol. source
Not checked in the free run.
- Premisecitation
Hepatic and plasma levels of tsukushi are strongly stimulated by stimuli that augment thermogenesis and energy expenditure, including adrenergic agonists and cold exposure.
“Hepatic and plasma levels of this hepatokine are strongly stimulated by stimuli that augment thermogenesis and energy expenditure (including adrenergic agonists and cold exposure) [78,88,89].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [78] Mouchiroud, 2019, The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis, JCI Insight source
Not checked in the free run.
- cites [88] Potthoff, 2021, Hepatokines and metabolism: Deciphering communication from the liver, Mol. Metab. source
Not checked in the free run.
- cites [89] Huang, 2021, Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer, Aging source
Not checked in the free run.
- Premisecitation
TNF-α and leptin seem to aggravate hypertension.
“These cytokines, especially TNF-α and leptin, seem to aggravate hypertension, which, together with visceral obesity, dyslipidemia, and hyperglycemia, configure the metabolic syndrome scenario [59,93].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In obese and diabetic individuals, visceral fat is related to the expression of IL-6 and TNF-α produced by macrophages that prevent or attenuate insulin signaling in insulin-dependent tissues.
“In obese and diabetic individuals, visceral fat is related to the expression of IL-6 and TNF-α produced by macrophages that prevent or attenuate insulin signaling in insulin-dependent tissues.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- Interpretationcitation
Myostatin has a role as a therapeutic target for managing metabolic disorders.
“Therefore, it is worth noting that myostatin has a role as a therapeutic target for managing these aforementioned metabolic disorders [45].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Mikolasevic, 2020, Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?, Can. J. Gastroenterol. Hepatol. source
Not checked in the free run.
- Premisereasoning
Myostatin has negative effects on metabolism.
“Present at the origin of several metabolic disorders, myostatin has negative effects on metabolism, and its levels are increased with physical inactivity and high levels of fat mass.”
Quote in the paperSubstantial claim - Premisenone given
ANGPTL3 is positively associated with glycemia and insulin levels in patients with insulin resistance.
“ANGPTL3 is expressed and release by the liver and works as a regulator of plasma triglyceride levels, positively associated with glycemia, and insulin levels in patients with insulin resistance.”
Quote in the paperNot a substantial claim - Premisecitation
These cytokines appear to exhibit a protective effect on the endothelium and vascular smooth muscle, preventing atherosclerosis.
“Beyond that, these cytokines appear to exhibit a protective effect on the endothelium and vascular smooth muscle, preventing atherosclerosis [103].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Byun, K., and Lee, S. (2020). The potential role of irisin in vascular function and atherosclerosis: A review. Int. J. Mol. Sci., 21. source
Not checked in the free run.
- Premisecitation
Myostatin contributes to resistance to the action of insulin due to a decrease in phosphorylation of the insulin receptor, compromising the insulin signaling pathway.
“Its contribution to resistance to the action of insulin occurs due to the decrease in phosphorylation of insulin receptor, compromising the entire insulin signaling pathway necessary to trigger its cellular actions [11].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
IL-6 released during physical exercise can improve glucose and lipid metabolism.
“Despite this, IL-6 released during physical exercise can improve glucose and lipid metabolism, while plasma levels of TNF-α in exercise are reduced, although its expression in adipose tissue is not affected [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- Interpretationcitation
Hepassocin can be a relevant biomarker for analyzing risk states for diabetes.
“Therefore, hepassocin can be a relevant biomarker for analyzing risk states for diabetes and may be known by other names, such as fibrinogen-like protein 1 and hepatocyte-derived fibrinogen-related protein 1 (HFREP1) [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
In muscle aging, increased plasma levels of IL-6 and TNF-α, associated with loss of muscle strength, activate cell signaling pathways that lead to skeletal muscle atrophy.
“In muscle aging, increased plasma levels of IL-6 and TNF-α, associated with loss of muscle strength, activate cell signaling pathways that lead to skeletal muscle atrophy, which in turn induce resistance to IL-6, a condition that shares similarities with insulin or leptin resistance [98].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] Kirk, 2020, Muscle, bone, and fat crosstalk: The biological role of myokines, osteokines, and adipokines, Curr. Osteopor. Rep. source
Not checked in the free run.
- Interpretationcitation
This environment constitutes fertile soil for atherosclerosis's chronic inflammatory process, a prelude to several cardiovascular conditions.
“This environment constitutes fertile soil for atherosclerosis’s chronic inflammatory process, a prelude to several cardiovascular conditions [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Barbalho, S.M., Flato, U.A.P., Tofano, R.J., Goulart, R.A., Guiguer, E.L., Detregiachi, C.R.P., Buchaim, D.V., Araújo, A.C., Buchaim, R.L., and Reina, F.T.R. (2020). Physical exercise and myokines: Relationships with sarcopenia and cardiovascular complications. Int. J. Mol. Sci., 21. source
Not checked in the free run.
- Premisecitation
Angptl8 is a hepatokine related to the reset of diurnal rhythms of the hepatic clock and metabolic genes in mice.
“Angptl8 is a hepatokine related to the reset of diurnal rhythms of hepatic clock, and metabolic genes in mice [88,90,91].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [88] Potthoff, 2021, Hepatokines and metabolism: Deciphering communication from the liver, Mol. Metab. source
Not checked in the free run.
- cites [90] Li, S., Li, J., Pan, R., Cheng, J., Cui, Q., Chen, J., and Yuan, Z. (2021). Sodium rutin extends lifespan and health span in mice including positive impacts on liver health. Br. J. Pharmacol. source
Not checked in the free run.
- cites [91] Hou, 2020, The ANGPTL8 rs2278426 (C/T) polymorphism is associated with prediabetes and type 2 diabetes in a han Chinese population in Hebei province, Int. J. Endocrinol. source
Not checked in the free run.
- Interpretationcitation
The network of adipokines, myokines, and hepatokines may have beneficial or non-beneficial effects on the genesis of various physiological disorders and their outcomes, such as DM2, obesity, metabolic syndrome, and CVD.
“Far beyond understanding each adipokine, myokine, or hepatokine’s actions alone, it is important to underline that these cytokines act together in the body, forming a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders, and their respective outcomes, such as DM2, obesity, metabolic syndrome, and CVD”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Faramia, 2020, Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines, Curr. Opin. Pharmacol. source
Not checked in the free run.
- Premisecitation
Physical exercise influences the predominance of the secretion of anti-inflammatory myokines, adipokines, and hepatokines, such as irisin, IL-6, IL-15, myonectin, adiponectin, and FGF21.
“For these reasons, physical exercise is a powerful ally in the prevention and improvement of the prognosis of cardiovascular diseases, DM2, and obesity, since it influences the predominance of the secretion of anti-inflammatory myokines, adipokines, and hepatokines, such as irisin, IL-6, IL -15, myonectin, adiponectin, FGF21 (which mitigate the harmful effects of myostatin), TNF-α, resistin, cheme”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Chen, 2020, Myokines mediate the cross talk between skeletal muscle and other organs, J. Cell. Physiol. source
Not checked in the free run.
- Interpretationcitation
Assessment of circulating adipokines may be relevant in the analysis of cardiometabolic risk.
“Therefore, the assessment of circulating adipokines may be relevant in the analysis of cardiometabolic risk [110].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Ouerghi, 2020, Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males, Cytokine source
Not checked in the free run.
- Interpretationcitation
Lower adropin expression may play an important role in the progression of NAFLD to severe NASH.
“It is also negatively related to the pathological changes in NAFLD, suggesting that the lower adropin expression may play an important role in the progression of NAFLD to severe NASH.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Chen, X., Sun, X., Shen, T., Chen, Q., Chen, S., Pang, J., Mi, J., Tang, Y., You, Y., and Xu, H. (2020). Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radic. Biol. Med., 160. source
Not checked in the free run.
- Premisecitation
Adropin increases fibronectin and elastin expression in vascular smooth muscle cells (VSMCs) by overloading the PI3K-Akt pathway.
“In this scenario, it was also observed that adropin increases fibronectin and elastin expression in vascular smooth muscle cells (VSMCs) by overloading the PI3K-Akt pathway, thus assuming that adropin regulates plaque stability and elasticity vascular [112].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Mushala, 2021, Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism, Am. J. Physiol. Circ. Physiol. source
Not checked in the free run.
- Premisecitation
The main hepatokines related to insulin resistance, a fundamental factor in the development of DM2 and obesity, are fetuin-A, hepassocin, LECT2, and selenoprotein.
“The main hepatokines related to insulin resistance, a fundamental factor in the development of DM2 and obesity, are fetuin-A, hepassocin, LECT2, and selenoprotein.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Potthoff, 2021, Hepatokines and metabolism: Deciphering communication from the liver, Mol. Metab. source
Not checked in the free run.
- Premisecitation
FGF21 is essential for controlling glucose and lipid metabolism.
“Substances that act as adipokines, myokines, and hepatokines, such as FGF21, are essential for controlling glucose and lipid metabolism.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [106] Degirolamo, 2016, Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23, Nat. Rev. Drug Disc. source
Not checked in the free run.
- cites [107] Keipert, 2020, Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
Adiponectin and omentin-1 may be positively associated with cardiometabolic health.
“Elevated levels of leptin and chemerin, for example, may be negatively associated with cardiometabolic health, just as adiponectin and omentin-1 may be positively associated.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Ouerghi, 2020, Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males, Cytokine source
Not checked in the free run.
- Premisecitation
The hepatokine most positively associated with CVD is adropin.
“Subsequently, the hepatokine most positively associated with CVD is adropin.”
Quote in the paperNot a substantial claim - Interpretationreasoning
FGF21 is an important therapeutic target of protection against muscle and liver insulin resistance induced by lipids and DM2.
“As such, it is an important therapeutic target of protection against muscle and liver insulin resistance induced by lipids and DM2 [106,107].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [106] Degirolamo, 2016, Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23, Nat. Rev. Drug Disc. source
Not checked in the free run.
- cites [107] Keipert, 2020, Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?, Front. Endocrinol. source
Not checked in the free run.
- Premisecitation
Adropin is negatively related to the pathological changes in NAFLD.
“It is also negatively related to the pathological changes in NAFLD, suggesting that the lower adropin expression may play an important role in the progression of NAFLD to severe NASH.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] Chen, X., Sun, X., Shen, T., Chen, Q., Chen, S., Pang, J., Mi, J., Tang, Y., You, Y., and Xu, H. (2020). Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radic. Biol. Med., 160. source
Not checked in the free run.
- Premisecitation
Follistatin directly protects β cells when induced by exercise, together with irisin.
“It has also been identified that follistatin directly protects β cells when induced by exercise, together with irisin [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- Premisecitation
Elevated levels of leptin and chemerin may be negatively associated with cardiometabolic health.
“Elevated levels of leptin and chemerin, for example, may be negatively associated with cardiometabolic health, just as adiponectin and omentin-1 may be positively associated.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Ouerghi, 2020, Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males, Cytokine source
Not checked in the free run.
- Premisecitation
Fetuin-B positively correlates with LDL-c levels.
“Finally, fetuin-B also negatively impacts metabolism because its serum level is higher in patients with coronary artery disease, especially in those with the acute coronary syndrome, and it still positively correlates with LDL-c levels [114].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Zhu, 2017, Increased serum levels of fetuin B in patients with coronary artery disease, Endocrine source
Not checked in the free run.
- Premisecitation
Fetuin-A can promote lipotoxicity in β cells through the TLR4-JNK-NF-kB signaling pathway.
“In addition to insulin resistance, fetuin-A can also promote lipotoxicity in β cells through the TLR4-JNK-NF-kB signaling pathway [65].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Shen, 2015, Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity, Mol. Cell. Endocrinol. source
Not checked in the free run.
- May combine two claims. 121
- Classified as probably not a substantial claim. 22
May combine two claims.
PremisecitationOxidative stress and inflammation can impair insulin signaling and promote development of comorbidities such as type 2 diabetes mellitus, hypertension, and cardiovascular complications.
“can impair insulin signaling and promote the development of comorbidities, such as type 2 diabetes mellitus (DM2), hypertension, and other factors that induce cardiovascular complications. [2].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Sofra, 2020, Adverse effects of sedentary lifestyles: Inflammation, and high-glucose induced oxidative stress—A double blind randomized clinical trial on diabetic and prediabetic patients, Health source
Not checked in the free run.
May combine two claims.
PremisecitationAdiponectin acts on insulin sensitivity, and its plasma reduction is related to insulin resistance and glucose intolerance, predisposing to advanced liver injury.
“It acts on insulin sensitivity, and its plasma reduction is related to insulin resistance and glucose intolerance, predisposing to advanced liver injury [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Buechler, C., Haberl, E.M., Rein-Fischboeck, L., and Aslanidis, C. (2017). Adipokines in liver cirrhosis. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
Premisenone givenAdiponectin is an antisteatotic, anti-inflammatory, and antifibrotic adipokine expressed by adipocytes from white and brown adipose tissue.
“Adiponectin, an antisteatotic, anti-inflammatory, and antifibrotic adipokine, is expressed by adipocytes from WAT and brown adipose tissue (BAT).”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenLeptin increases oxidation and absorption of glucose and free fatty acid in skeletal muscles and promotes intrahepatic lipid reduction through fatty acid oxidation.
“In addition, leptin increases the oxidation and absorption of glucose and free fatty acid (FFA) in skeletal muscles and promotes intrahepatic lipid reduction through fatty acid oxidation (Figure 1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEating behavior, delimited by cultural and social aspects, has a substantial impact on health conditions and the development of cardiovascular diseases and inflammatory complications.
“Eating behavior, delimited by cultural and social aspects, has a substantial impact on health conditions and the development of cardiovascular diseases and inflammatory complications [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Huber, B.C., Steffen, J., Schlichtiger, J., and Brunner, S. (2020). Altered nutrition behavior during COVID-19 pandemic lockdown in young adults. Eur. J. Nutr. source
Not checked in the free run.
May combine two claims.
PremisecitationIn obesity, adipose tissue hypertrophy is directly related to chronic low-grade inflammation and an increase in chemotactic molecules, reduction in adiponectin levels, and onset of leptin resistance.
“In obesity, its hypertrophy is directly related to chronic low-grade inflammation and an increase in chemotactic molecules, in addition to a reduction in adiponectin levels and the onset of leptin resistance.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [10] Faramia, 2020, Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines, Curr. Opin. Pharmacol. source
Not checked in the free run.
- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- cites [13] Song, P., Kwon, Y., Joo, J.Y., Kim, D.G., and Yoon, J.H. (2019). Secretomics to discover regulators in diseases. Int. J. Mol. Sci., 20. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMetreleptin is a recombinant methyl-human leptin hormone showing efficacy in children with congenital leptin deficiency for reversal of obesity and metabolic improvement.
“Metreleptin is a recombinant methyl-human leptin hormone showing efficacy in children with congenital leptin deficiency reversal of obesity and metabolic improvement [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Farooqi, 1999, Effects of recombinant leptin therapy in a child with congenital leptin deficiency, N. Engl. J. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationIn obesity, increase in leptin levels is associated with leptin resistance and increase in reactive oxygen species, IL-6, TNF-alpha, and chemokines.
“In obesity, the increase in leptin levels is associated with the state of leptin resistance, in addition to the increase in reactive oxygen species (ROS), IL-6, TNF-α, and chemokines.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
PremisecitationLeptin stimulates division of hepatic stellate cells and synthesis of pro-fibrogenic and pro-inflammatory factors in these cells, and induces synthesis of TGF-beta in Kupffer cells.
“Leptin stimulates the division of hepatic stellate cells and the synthesis of pro-fibrogenic and pro-inflammatory factors in these cells; moreover, it induces the synthesis of transforming growth factor b (TGFβ) in Kupffer cells [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Merli, 2019, Sarcopenic obesity in fatty liver, Curr. Opin. Clin. Nutr. Metab. Care source
Not checked in the free run.
May combine two claims.
Premisenone givenLeptin acts as an endocrine signal by reducing appetite and stimulating energy expenditure by activating POMC-expressing neurons and inhibiting hypothalamic AgRP and NPY.
“acts as an endocrine signal by reducing appetite and stimulating energy expenditure by activating pro-opiomelanocortin (POMC)—expressing neurons, inhibiting the hypothalamus agouti-related protein (AgRP) and neuropeptide Y (NPY).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLeptin and adiponectin are classic adipokines of adipose tissue and have a substantial relationship in the pathogenesis of obesity and metabolic complications.
“Leptin and adiponectin (Table 1) are the classic adipokines of adipose tissue and have a substantial relationship in the pathogenesis of obesity and metabolic complications [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Lund, 2020, Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity, Pediatr. Diab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe main circulating form of omentin is omentin-1, known as interleukin-1, expressed in visceral adipose tissue, and its levels are regulated by FGF-21, dexamethasone, glucose, and insulin.
“The main circulating form of omentin is omentin-1, known as interleukin-1, expressed in visceral tissue adipose, and its levels are regulated by fibroblast growth factor-21, dexamethasone, glucose, and insulin [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Watanabe, 2017, Adipose tissue-derived omentin-1 function and regulation, Compr. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 is produced by macrophages and stimulated by activation of NF-kappaB and acts in inhibiting expression of IRS1 and GLUT4 in adipocytes.
“It is produced by macrophages and stimulated by the activation of the nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) and acts in inhibiting the expression of insulin receptor substrate 1 (IRS1) and glucose transporter type 4 (GLUT4) in adipocytes [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationAsprosin is an orexigenic hormone induced by fasting and produced by white adipose tissue; it increases food consumption and body weight through AgRP neurons and accelerates liver glucose production by activating the G protein-cAMP-PKA pathway.
“It is an orexigenic hormone induced by fasting and produced by WAT, and increases food consumption and body weight through Agouti-related protein neurons (AgRP), and accelerates the production of liver glucose, activating the G protein-cAMP-protein kinase A (PKA) pathway [16,17].”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAsprosin is associated with modulation of cardiac mitochondrial functions, and in patients with dilated cardiomyopathy, elevated asprosin level is associated with fewer adverse cardiovascular issues in five years.
“Another interesting study showed that asprosin is associated with the modulation of cardiac mitochondrial functions and in patients with dilated cardiomyopathy patients, elevated asprosin level is associated with less adverse cardiovascular issues in five years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Wen, M.S., Wang, C.Y., Yeh, J.K., Chen, C.C., Tsai, M.L., Ho, M.Y., Hung, K.C., and Hsieh, I.C. (2020). The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc. Dis., 20. source
Not checked in the free run.
May combine two claims.
PremisecitationFGF21 increases expression of UCP1 and other thermogenic genes and stimulates expression of adiponectin in the bloodstream and white adipose tissue.
“In addition, it increases the expression of uncoupling protein 1 (UCP1) and other thermogenic genes and stimulates the expression of adiponectin in the bloodstream and WAT [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Mehta, 2019, Fibroblast growth factor 21 and browning of white adipose tissue, Front. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationSFRP5 is associated with comorbidities such as obesity, type 2 diabetes mellitus, insulin resistance, and atherosclerosis, inhibiting Wnt5a and non-canonical Wnt family and regulating expression of pro-inflammatory cytokines.
“SFRP5 is associated with comorbidities such as obesity, DM2, insulin resistance, and atherosclerosis, inhibiting the wingless-type family member 5a signaling (Wnt5a) and the non-canonical Wnt family and regulating the expression of pro-inflammatory cytokines [14,21].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
- cites [21] Wang, 2020, Sfrp5/Wnt5a and leptin/adiponectin levels in the serum and the periarterial adipose tissue of patients with peripheral arterial occlusive disease, Clin. Biochem. source
Not checked in the free run.
May combine two claims.
Premisenone givenAdiponectin contributes significantly to anti-inflammatory action, thermogenesis, lipolysis, and oxidation of fatty acids in skeletal muscle and liver.
“This adipokine contributes significantly to anti-inflammatory action, thermogenesis, lipolysis, and oxidation of fatty acids in skeletal muscle and liver.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenSPARC is expressed in most tissues and is one of the proteins in the extracellular matrix of adipose tissue.
“Although initially found in bone tissue, SPARC is expressed in most tissues, being one of the proteins in the extracellular matrix of adipose tissue.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVaspin improves glucose intolerance and insulin sensitivity and reduces synthesis of pro-inflammatory cytokines.
“However, the function of vaspin is to improve glucose intolerance and insulin sensitivity and reduce the synthesis of pro-inflammatory cytokines [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Kukla, 2020, Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma, Clin. Exp. Hepatol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenCTRP action occurs through several receptors, including adipoR1 and adipoR2.
“Its action occurs through several receptors, including adipoR1 and adipoR2.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAsprosin is encoded by the FBN1 locus and has a role in mediation of the lipodystrophy phenotype.
“Asprosin, which is encoded by the FBN1 locus, has a role in the mediation of the lipodystrophy phenotype [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Lin, 2020, Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1, Mol. Genet. Genom. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationPlasma levels of adiponectin can be reduced with increase in pro-inflammatory cytokines TNF-alpha and IL-6 present in obesity, in addition to levels of myostatin, a myokine that can elevate adipose tissue mass.
“Plasma levels of adiponectin can be reduced with the increase in pro-inflammatory cytokines such as TNF-α and IL-6, present in obesity, in addition to the levels of myostatin, a myokine that can elevate the adipose tissue mass [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Mikolasevic, 2020, Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?, Can. J. Gastroenterol. Hepatol. source
Not checked in the free run.
May combine two claims.
PremisecitationObese people have a high concentration of asprosin, and it is closely related to insulin resistance in humans, with higher serum asprosin levels identified in patients with type 2 diabetes mellitus.
“In a clinical study, it was found that obese people have a high concentration of asprosin, and it is also closely related to insulin resistance in humans, which is proven when higher serum levels of asprosin are identified in patients with DM2 [49].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Kim, 2020, Newly discovered adipokines: Pathophysiological link between obesity and cardiometabolic disorders, Front. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationFSTL1 is an adipokine and myokine reported as a pre-adipocyte/adipocyte-secreted protein, has pro-inflammatory action, and has a possible relationship with overweight and obesity.
“Follistatin-like 1 (FSTL1), an adipokine and myokine reported as a pre-adipocyte/adipocyte-secreted protein, has a pro-inflammatory action and possible relationship with overweight and obesity.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenOmentin acts to improve insulin sensitivity and glucose absorption and acts as an anti-atherosclerotic factor.
“In turn, omentin acts to improve insulin sensitivity and glucose absorption and acts as an anti-atherosclerotic factor.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenChemerin is secreted as an inactive molecule, is activated by inflammatory and coagulation serine proteases, accentuates glucose intolerance, and makes insulin signaling difficult.
“On the other hand, the adipokine named chemerin, which is secreted and an inactive molecule, is activated by inflammatory and coagulation serine proteases, accentuates glucose intolerance, and makes insulin signaling difficult.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenFAM19A5 is released by adipose tissue, and its expression is reduced in obesity.
“On the other hand, the family with sequence similarity to 19 member A5 (FAM19A5), initially demonstrated in mice, is released by adipose tissue, and its expression is reduced in obesity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAdiponectin action begins with binding to AdipoR1 or 2 receptors and activation of AMPK, leading to reduced lipogenesis and gluconeogenesis and increased glucose absorption by skeletal muscle and white adipose tissue.
“Its action begins with the binding to its AdipoR1 or 2 receptors and the activation of AMP-activated protein kinase (AMPK), leading to reduced lipogenesis and gluconeogenesis and increased glucose absorption by skeletal muscle and WAT [46].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Fang, 2018, Adiponectin regulation and function, Comprehensive Physiology source
Not checked in the free run.
May combine two claims.
PremisecitationIn humans, FGF21 is responsible for browning of white adipose tissue, activation of brown adipocytes, and lipolysis.
“In humans, FGF21 is responsible for the browning of WAT, activation of brown adipocytes, and lipolysis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVaspin is a protein that inhibits serine protease, is found in greater quantities in obese individuals with type 2 diabetes mellitus, and is expressed by adipose tissue and skeletal muscle.
“In the same perspective, visceral adipose tissue-derived serpin (vaspin), a protein that inhibits serine protease, is also found in greater quantities in obese individuals with DM2 and expressed by adipose tissue and skeletal muscle [53].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Nicholson, T., Church, C., Tsintzas, K., Jones, R., Breen, L., Davis, E.T., Baker, D.J., and Jones, S.W. (2019). Vaspin promotes insulin sensitivity of elderly muscle and is upregulated in obesity. J. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationChemerin acts through ChemR23, and its receptors are mostly concentrated in adipose tissue and hepatocytes, despite existing throughout the human body.
“Its action occurs through the chemerin receptor (ChemR) 23, and its receptors are mostly concentrated in adipose tissue and hepatocytes, despite existing throughout the human body [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCTRPs are a family of adipokines with a structure similar to adiponectin, involved in regulation of glucose and fat metabolism in peripheral tissues, food intake, and inflammatory processes of adipose tissue.
“C1q/TNF-related proteins (CTRPs) are related to a family of adipokines with a structure similar to adiponectin, involved in the regulation of glucose and fat metabolism in peripheral tissues, food intake, and inflammatory processes of adipose tissue [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Lei, 2017, C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationResistin is a mediator of obesity-related insulin resistance, a pro-inflammatory adipokine correlated with fat mass that acts on endothelial dysfunction and cardiovascular diseases.
“Resistin, a mediator of obesity-related insulin resistance, is a pro-inflammatory adipokine correlated with fat mass that acts on endothelial dysfunction and cardiovascular diseases [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Musovic, 2020, Resistin is co-secreted with adiponectin in white mouse adipocytes, Biochem. Biophys. Res. Commun. source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 in adipose tissue has pro-inflammatory characteristics, is directly related to BMI, and is augmented in individuals with insulin resistance, obesity, and type 2 diabetes mellitus.
“In the same perspective, IL-6, in adipose tissue, has pro-inflammatory characteristics, being directly related to the BMI, and is augmented in individuals with insulin resistance, obesity, and DM2.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn mice, CTRP6 expression, regulated for adipose tissue in obesity and diabetes, is secreted by stromal vascular cells and macrophages, and its increased expression substantially compromised glucose disposal in peripheral tissues.
“Studies in mice have demonstrated that the expression of CTRP6, regulated for adipose tissue in obesity and diabetes, is secreted by stromal vascular cells and macrophages, and its increased expression substantially compromised the disposal of glucose in peripheral tissues [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Recinella, 2020, Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases, Front. Physiol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenFetuin-A is classically considered a hepatokine, is a natural insulin inhibitor tyrosine kinase, and is associated with insulin resistance and inflammation in rodents and humans.
“Fetuin-A (Fet-A), classically considered a hepatokine, is a natural insulin inhibitor tyrosine kinase and is associated with insulin resistance and inflammation in rodents and humans.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenWISP1 is an adipokine associated with extracellular matrix, expressed for visceral and subcutaneous adipose tissue, and stimulates cytokine response in macrophages associated with adipose tissue.
“From the same perspective, the wingless-type inducible signaling pathway protein-1 (WISP1), an adipokine associated with the extracellular matrix, is expressed for visceral and subcutaneous tissue adipose and stimulates the cytokine response in macrophages associated with tissue adipose.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenApelin is released mainly in resistance exercises and has an anti-inflammatory role and essential actions in metabolism, control of cardiac muscles and blood pressure, new vessel formation, and control of cell cycle and death.
“Apelin, released mainly in resistance exercises, has an important anti-inflammatory role and other essential actions in metabolism, control of cardiac muscles and blood pressure, new vessels’ formation, and control of cell cycle and death.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenProgranulin is secreted by adipocytes from visceral adipose tissue, macrophages, chondrocytes, and other cells, and has anti-inflammatory properties due to competition with TNFR1 and TNFR2.
“On the other hand, the glycoprotein progranulin, secreted by adipocytes from visceral tissue adipose, macrophages, chondrocytes, and other cells, has anti-inflammatory properties due to competition with TNF-α receptors (TNFR1 and TNFR2).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEach myokine appears to be related to a specific type of muscle fiber and different physical exercise modalities.
“Each myokine appears to be related to a specific type of muscle fiber and different physical exercise modalities [56] (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barbalho, 2020, Myokines: A descriptive review, J. Sports Med. Phys. Fitness source
Not checked in the free run.
May combine two claims.
InterpretationreasoningInduction of adipocyte browning by irisin suppresses adipogenesis and cholesterol synthesis and optimizes lipid oxidation and lipidic homeostasis.
“Therefore, induction of adipocyte browning by irisin suppresses adipogenesis and cholesterol synthesis and optimizes lipid oxidation and lipidic homeostasis by extension.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMyokines are expressed mainly in physical activities or absence, allowing communication with other body tissues, showing actions that can be beneficial for most myokines or related to metabolic dysfunctions.
“These molecules are expressed mainly in physical activities or absence, allowing its communication with other body tissues, thereby showing actions that can be considered beneficial for most myokines or related to metabolic dysfunctions [8,14].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8] Barbalho, S.M., Flato, U.A.P., Tofano, R.J., Goulart, R.A., Guiguer, E.L., Detregiachi, C.R.P., Buchaim, D.V., Araújo, A.C., Buchaim, R.L., and Reina, F.T.R. (2020). Physical exercise and myokines: Relationships with sarcopenia and cardiovascular complications. Int. J. Mol. Sci., 21. source
Not checked in the free run.
- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationIn a clinical study by Mikolajczak et al., FGF21 levels are increased in obesity, possibly as an adaptive mechanism against insulin resistance and its consequences.
“Despite this, the clinical study by Mikolajczak et al. showed that FGF21 levels are increased in the state of obesity, possibly as an adaptive mechanism against insulin resistance and its consequences [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Mikolajczak, 2017, Serum FGF21 in girls with anorexia nervosa—Comparison to normal weight and obese female adolescents, Neuro Endocrinol. Lett.
Not checked in the free run.
May combine two claims.
PremisereasoningDespite its pro-inflammatory label, IL-6 levels increase after physical exercise, which promotes secretion of IL-10, an IL-1 antagonist and possible inhibitor of TNF-alpha, characterizing an anti-inflammatory environment after increased IL-6 released by muscle tissue.
“Despite the pro-inflammatory cytokine label, mainly due to their role as an adipokine, IL-6 levels are increased after physical exercises, which promotes the secretion of interleukin-10 (IL-10), an IL-1 antagonist and possible inhibitor of TNF-α, characterizing an anti-inflammatory environment after increasing the concentration of IL-6 released by muscle tissue.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenFollistatin is a myokine and hepatokine, released in the context of physical activity, which opposes myostatin's actions by directly inhibiting it through binding.
“In contrast, there is follistatin, a myokine, and hepatokine, released in the context of physical activity, which is opposed to myostatin’s actions, directly inhibiting it through binding.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationZAG regulates lipogenesis and lipolysis enzymes, stimulates adiponectin production, and promotes browning of white adipose tissue.
“Its action is in regulating lipogenesis and lipolysis enzymes, in the stimulation of adiponectin production, and the browning of WAT.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenVisfatin is an adipokine secreted by adipose tissue, a class type II phosphoribosyltransferase homodimer, and increases in obese people.
“Another adipokine secreted by adipose tissue is visfatin, a class type II phosphoribosyltransferase homodimer, which increases in obese people.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVisfatin secretion is more significant in subcutaneous adipose tissue and is associated with enzymatic activity such as NAMPT.
“Its secretion is more significant in the subcutaneous adipose tissue and is associated with an enzymatic activity such as nicotinamide phosphoribosyltransferase (NAMPT) [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Franco-Trepat, E., Guillán-Fresco, M., Alonso-Pérez, A., Jorge-Mora, A., Francisco, V., Gualillo, O., and Gómez, R. (2019). Visfatin connection: Present and future in osteoarthritis and osteoporosis. J. Clin. Med., 8. source
Not checked in the free run.
May combine two claims.
PremisecitationStudies point to a relationship between high levels of irisin and low atherosclerosis burden in coronary arteries, proving its cardioprotective effects.
“Studies point to a relationship between high levels of irisin and low atherosclerosis burden in coronary arteries, proving its cardioprotective effects [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Barbalho, S.M., Flato, U.A.P., Tofano, R.J., Goulart, R.A., Guiguer, E.L., Detregiachi, C.R.P., Buchaim, D.V., Araújo, A.C., Buchaim, R.L., and Reina, F.T.R. (2020). Physical exercise and myokines: Relationships with sarcopenia and cardiovascular complications. Int. J. Mol. Sci., 21. source
Not checked in the free run.
May combine two claims.
PremisecitationFollistatin contributes to increase in muscle mass, optimizing glucose uptake by skeletal muscle and white adipose tissue lipolysis.
“Thus, follistatin contributes to the increase in muscle mass, optimizing glucose uptake by SkM and WAT lipolysis [11,13].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- cites [13] Song, P., Kwon, Y., Joo, J.Y., Kim, D.G., and Yoon, J.H. (2019). Secretomics to discover regulators in diseases. Int. J. Mol. Sci., 20. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationMyostatin inhibition may be a therapeutic target for muscle mass loss disorders such as atrophy, sarcopenia, and cancer.
“Possibly, myostatin inhibition may be a therapeutic target for muscle mass loss disorders, such as atrophy, sarcopenia, and cancer [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Mikolasevic, 2020, Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?, Can. J. Gastroenterol. Hepatol. source
Not checked in the free run.
May combine two claims.
PremisecitationFGF21 increases insulin sensitivity, reduces plasma glucose levels, and has lipolytic activity that decreases plasma triglyceride levels.
“It increases insulin sensitivity, reduces plasma glucose levels, and has lipolytic activity, which decreases plasma triglyceride levels [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Faramia, 2020, Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines, Curr. Opin. Pharmacol. source
Not checked in the free run.
May combine two claims.
PremisecitationA drop in myonectin levels, which can be caused by physical inactivity or a high-fat diet, is related to excess circulating free fatty acids and subsequent accumulation in other tissues and insulin resistance.
“A drop in myonectin levels, which can be caused by physical inactivity or a high-fat diet, is related to excess circulating FFA and subsequent accumulation in other tissues and insulin resistance [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Mehta, 2019, Fibroblast growth factor 21 and browning of white adipose tissue, Front. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationIL-15 helps in reduction of visceral adipose tissue without reducing subcutaneous fat, showing performance in muscle-fat crosstalk.
“Additionally, it helps in the reduction in visceral adipose tissue without reducing subcutaneous fat, showing performance in muscle-fat crosstalk [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenNesfatin-1 is involved in energy homeostasis and satiety induction and is described as an anorexigenic molecule secreted by subcutaneous adipose tissue, pancreatic cells, gastric mucosa, and hypothalamus.
“Nesfatin-1, in turn, involved in energy homeostasis and satiety induction, is described as an anorexigenic molecule secreted by subcutaneous adipose tissue, pancreatic cells, gastric mucosa, and hypothalamus.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIrisin is a transmembrane protein with a type III fibronectin domain secreted after physical exercise, which participates in browning of white adipose tissue by increasing UCP1 and respiratory chain of brown adipose tissue, promoting energy expenditure especially as heat, contributing to weight loss.
“It is a transmembrane protein with a type III fibronectin domain secreted after physical exercise, which has shown participation in the browning of white tissue adipose (WAT) process by increasing the expression of uncoupling protein-1, the respiratory chain of BAT, which promotes energy expenditure especially in the form of heat, contributing to weight loss [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
Premisenone givenMyonectin is released in resistance modalities and acts on lipid metabolism, increasing lipid uptake by adipose tissue and liver and decreasing plasma free fatty acid concentration.
“Furthermore, released in resistance modalities, myonectin acts on the metabolism of lipids, increasing their uptake by adipose tissue and liver, thus decreasing the plasma concentration of FFA.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenIL-6 is the first myokine described, often characterized as a pro-inflammatory cytokine produced by various tissues, and is considered a myokine, adipokine, and hepatokine.
“Interleukin-6 (IL-6), the first myokine to be described, is often characterized as a pro-inflammatory cytokine produced by various tissues, being considered myokines, adipokines, and hepatokine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVisfatin in high concentrations causes insulin resistance and pancreatic beta-cell dysfunction and produces inflammation in adipocytes.
“Visfatin in high concentrations causes insulin resistance and pancreatic beta-cell dysfunction and produces inflammation in adipocytes [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Kumari, 2018, Adipokine visfatin’s role in pathogenesis of diabesity and related metabolic derangements, Curr. Mol. Med. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome experimental studies point to a possible correlation between increased levels of IL-6 and inhibition of appetite.
“Moreover, some experimental studies point to a possible correlation between increased levels of IL-6 and inhibition of appetite [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Yuan, 2020, Asprosin: A novel player in metabolic diseases, Front. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationIrisin appears to increase insulin sensitivity, promoting glucose transporter mobilization in insulin-dependent tissues, and improves metabolic syndrome and cardiovascular disease.
“In addition, irisin appears to increase insulin sensitivity, promoting glucose transporter mobilization in insulin-dependent tissues, and improves metabolic syndrome and CVD.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenIL-15 has anti-inflammatory properties, mainly by inhibiting expression of TNF-alpha, which plays a role in oxidative stress.
“IL-15 has anti-inflammatory properties, mainly by inhibiting the expression of TNF-α, which plays a role in oxidative stress.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIL-15 prevents reduction in muscle mass and increases uptake of glucose by skeletal muscle by stimulating mobilization of GLUT4, contributing to muscle hypertrophy.
“It also prevents the reduction in muscle mass and increases the uptake of glucose by skeletal muscle by stimulating the mobilization of glucose transporters 4 (GLUT 4), contributing to muscle hypertrophy [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Shi, 2019, Cytokines and abnormal glucose and lipid metabolism, Front. Endocrinol. source
Not checked in the free run.
May combine two claims.
Premisenone givenFGF21 is produced by several tissues and is classified as a myokine, adipokine, and hepatokine.
“Fibroblast growth factor 21 (FGF21) is produced by several tissues classified as myokine, adipokines, and hepatokine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn rodents, injections of nesfatin-1 inhibit food intake, and its lack in the brain causes an increase in appetite, fat, and body weight.
“In rodents, injections of nesfatin-1 inhibit food intake, and its lack in the brain causes an increase in appetite, fat, and body weight.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningReduction in muscle mass mediated by myostatin facilitates appearance of metabolic disorders such as insulin resistance and accumulation of fat in liver, since skeletal muscle is the main source of glucose-dependent glucose uptake.
“This reduction in muscle mass, mediated by myostatin, facilitates the appearance of metabolic disorders, such as resistance to insulin and accumulation of fat in the liver, since skeletal muscle is the main source of glucose-dependent glucose uptake.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationZAG is expressed by both white and brown adipose tissue and directly accelerates lipid metabolism.
“On the other hand, the adipokine zinc-α2-glycoprotein (ZAG) is expressed by both white and BAT and directly accelerates lipid metabolism [38].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Zhang, 2020, Zinc-α2-glycoprotein knockout influenced genes expression profile in adipose tissue and decreased the lipid mobilizing after dexamethasone treatment in mice, Horm. Metab. Res. source
Not checked in the free run.
May combine two claims.
InterpretationcitationMyonectin shows positive effects on the cardiovascular system, which may reveal a potential therapeutic target in cardiovascular disease treatment.
“This myokine shows positive effects on the cardiovascular system, which may reveal a potential therapeutic target in CVD treatment [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Barbalho, S.M., Flato, U.A.P., Tofano, R.J., Goulart, R.A., Guiguer, E.L., Detregiachi, C.R.P., Buchaim, D.V., Araújo, A.C., Buchaim, R.L., and Reina, F.T.R. (2020). Physical exercise and myokines: Relationships with sarcopenia and cardiovascular complications. Int. J. Mol. Sci., 21. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNesfatin-1 can regulate gastric distension and motility via the melanocortin pathway in the central nucleus of the amygdala.
“In addition, nesfatin-1 can regulate gastric distension and motility via the melanocortin pathway in the central nucleus of the amygdala [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Recinella, 2020, Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases, Front. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationHyperprogranulinemia present in obesity is associated with insulin resistance and deficient insulin signaling, whereas progranulin deficiency can protect from diet-induced insulin resistance.
“However, hyperprogranulinemia present in obesity is associated with insulin resistance and deficient insulin signaling, whereas its deficiency can protect from diet-induced insulin resistance [31,32].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Abella, 2017, Leptin in the interplay of inflammation, metabolism and immune system disorders, Nat Rev. Rheumatol. source
Not checked in the free run.
- cites [32] Korolczuk, 2017, Progranulin, a new adipokine at the crossroads of metabolic syndrome, diabetes, dyslipidemia and hypertension, Curr. Pharm. Design source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, overexpression of adropin improves insulin sensitivity and glucose tolerance.
“On the other hand, it has been seen that in mice, the overexpression of adropin reduces weight gain, attenuates hepatosteatosis, increases fatty acid oxidation throughout the body, improves insulin sensitivity, and improves glucose tolerance [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationHepatokines are proteins produced by the liver that can worsen or improve metabolic conditions.
“Hepatokines are proteins produced by the liver that have recently been discovered as new hormones, which can worsen or improve metabolic conditions [64].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Choi, 2016, The impact of organokines on insulin resistance, inflammation, and atherosclerosis, Endocrinol. Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDecorin is involved in skeletal muscle hypertrophy.
“It is secreted by skeletal muscle cells and is involved in the skeletal muscle hypertrophy and regulates muscle growth with the practice of physical exercise [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., and Guzik, P. (2021). Effect of various exercise regimens on selected Exercise-induced cytokines in healthy people. Int. J. Environ. Res. Public Health, 18. source
Not checked in the free run.
May combine two claims.
Premisenone givenIn mice, plasma levels of adropin increase with feeding and decrease with fasting.
“Studies have shown that in mice, plasma levels of adropin increase with feeding and decrease with fasting.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFetuin-A concentration interferes with the insulin signaling cascade and the translocation of GLUT4 in insulin target tissues.
“This metabolic pattern is caused due to the concentration of fetuin-A interfering with the insulin signaling cascade and the translocation of GLUT4 in insulin target tissues [79].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Iroz, 2015, Hepatokines: Unlocking the multi-organ network in metabolic diseases, Diabetologia source
Not checked in the free run.
May combine two claims.
PremisecitationSome studies address the role of SPARC in activating caspase-3 and caspase-8 dependent apoptosis, which reveals a potential benefit of physical exercise in decreasing incidence of colon cancer.
“Some studies address the role of SPARC in activating caspase-3 and caspase-8 dependent apoptosis, which reveals a potential benefit of physical exercise in decreasing the incidence of colon cancer [60].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Aoi, 2019, Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation, FASEB J. source
Not checked in the free run.
May combine two claims.
PremisecitationBDNF is released by muscle and brain tissue after exercise; unlike other myokines, it is not released into the bloodstream.
“The brain-derived neurotrophic factor (BDNF) is also released by muscle and brain tissue after exercise; however, unlike other myokines, it is not released into the bloodstream [61].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Cooper, 2018, On the run for hippocampal plasticity, Cold Spring Harbor Perspect. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationSPARC is released in episodes of resistance exercises and muscle hypertrophy and is related to optimization of glucose uptake by increased expression and translocation of GLUT4 by activating AMPK signaling pathway.
“SPARC is released in episodes of resistance exercises and muscle hypertrophy and has also been related to the optimization of glucose uptake by increased expression and translocation of GLUT 4 by activating the AMPK signaling pathway [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barbalho, 2020, Myokines: A descriptive review, J. Sports Med. Phys. Fitness source
Not checked in the free run.
May combine two claims.
PremisecitationBDNF is related to glucose and lipid metabolism regulation and increased insulin sensitivity when released by muscle.
“Besides that, it is also related to glucose and lipid metabolism regulation and increased insulin sensitivity when released by muscle [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationExercise stimulates release of myokines such as cathepsin B and irisin, which cross the blood-brain barrier to induce cerebral BDNF secretion.
“The study performed by Pedersen [56] suggests that exercise stimulates the release of myokines, such as cathepsin B and irisin, which in turn cross the blood–brain barrier to induce cerebral BDNF secretion.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barbalho, 2020, Myokines: A descriptive review, J. Sports Med. Phys. Fitness source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenBDNF acts primarily on neurons through tyrosine receptor kinases, allowing their growth and survival and playing a fundamental role for memory and learning.
“This acts primarily on neurons through tyrosine receptor kinases (Trk), allowing their growth and survival and playing a fundamental role for memory and learning.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn vitro, endothelial cells treated with adropin had greater proliferation, migration, formation of a capillary-like tube, and positive regulation of eNOS expression.
“Still, in this respect, there is increasing evidence that adropin is a biomarker of cardiovascular dysfunction, initially because in vitro tests showed that endothelial cells treated with adropin had greater proliferation, migration, formation of a capillary-like tube, and positive regulation of the expression of nitric oxide endothelial synthase (eNOS).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Zhao, 2015, Serum adropin level in patients with stable coronary artery disease, Heart Lung Circulat. source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, overexpression of adropin reduces weight gain and attenuates hepatosteatosis.
“On the other hand, it has been seen that in mice, the overexpression of adropin reduces weight gain, attenuates hepatosteatosis, increases fatty acid oxidation throughout the body, improves insulin sensitivity, and improves glucose tolerance [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationSPARC is able to inhibit formation of adipose tissue, increase release of insulin, and promote erythropoiesis.
“It is also able to inhibit the formation of adipose tissue, increase the release of insulin and promote erythropoiesis [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationANGPTL4 acts on WAT, stimulating lipolysis and decreasing lipoprotein lipase (LPL) action.
“This hepatokine also acts on WAT, stimulating lipolysis and decreasing the enzyme lipoprotein lipase (LPL) action, that is, reducing the hydrolysis of triglycerides in circulating lipoproteins to FFA and reducing the accumulation of lipids in the white tissue adipose [75].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationHigh serum levels of seleno-protein are associated with metabolic diseases, insulin resistance, and increased reactive oxygen species (ROS) via activation of AMPK.
“When seleno-protein is found in high serum levels, it is associated with metabolic diseases, insulin resistance, and increased ROS via the activation of AMPK, and it influences the drop in concentrations of irisin, meteorin-like (METRNL), and β-aminoisobutyric acid (BAIBA), which consequently attenuates the loss of fat mass induced by physical exercises [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, follistatin overexpression is associated with insulin resistance in WAT, elevated hepatic glucose production, and glucose intolerance.
“In addition, studies with mice have shown that follistatin overexpression is associated with insulin resistance in WAT, elevated hepatic glucose production, and glucose intolerance [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased seleno-protein P increases insulin resistance, accumulates fat in adipose tissue, and aggravates risks of developing atherosclerosis.
“In addition, studies have shown that intermittent hypoxia generates stress that increases the levels of seleno-protein P in human hepatocytes, increasing insulin resistance, accumulating fat in adipose tissue, and aggravating risks of developing atherosclerosis [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
May combine two claims.
Premisenone givenChemerin is produced by the liver and contributes to a decrease in glucose homeostasis.
“Chemerin is not only an adipokine, but is also produced by the liver and contributes to the decrease in glucose homeostasis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFollistatin originates from the liver and rises when the glucagon-to-insulin ratio increases in the case of fasting and aerobic and resistance exercise.
“Follistatin originates from the liver and rises when the glucagon-to-insulin ratio increases in the case of fasting and aerobic and resistance exercise [74].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Perakakis, 2018, Physiology of activins/follistatins: Associations with metabolic and anthropometric variables and response to exercise, J. Clin. Endocrinol. Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationElevated LECT2 is associated with metabolic stress, which impairs insulin signal transduction.
“Thus, it has been shown that elevated LECT2 is associated with metabolic stress, which impairs insulin signal transduction, has a responsibility to promote and express adhesion molecules, and increases the appearance of pro-inflammatory cytokines.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationIn humans, activin E reduces lipolysis and increases fat accumulation in adipocytes.
“However, in humans, activin E has been reported to reduce lipolysis and increase fat accumulation in adipocytes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Sugiyama, M., Kikuchi, A., Misu, H., Igawa, H., Ashihara, M., Kushima, Y., Honda, K., Suzuki, Y., Kawabe, Y., and Kaneko, S. (2018). Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples. PLoS ONE, 13. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenOverexpression of ANGPTL6 results in insulin sensitivity and elevated energy expenditure.
“On the other hand, overexpression of this organokine results in insulin sensitivity and elevated energy expenditure.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPlasma levels of TNF-α in exercise are reduced, although its expression in adipose tissue is not affected.
“Despite this, IL-6 released during physical exercise can improve glucose and lipid metabolism, while plasma levels of TNF-α in exercise are reduced, although its expression in adipose tissue is not affected [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationMyostatin promotes the state of obesity, sarcopenia, and sarcopenic obesity.
“In parallel, myostatin promotes the state of obesity, sarcopenia, and sarcopenic obesity, which promotes the release of inflammatory adipokines and hepatokines while inhibiting the release of myokines and other anti-inflammatory and antioxidant organokines [14].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationAdipokines can modulate bone mineral density and bone turnover as well as skeletal muscle catabolism in aging.
“In addition to being involved in disease metabolism, adipokines can modulate bone mineral density and bone turnover as well as skeletal muscle catabolism in aging [97].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] Makowski, 2020, Chapter four—Myokines: The endocrine coupling of skeletal muscle and bone, Advances in Clinical Chemistry source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenANGPTL6 is highly expressed in obesity, augments lipid accumulation in skeletal muscle and liver, reduces energy expenditure, and increases insulin resistance.
“ANGPTL6 is highly expressed in obesity, augmented lipid accumulation in skeletal muscle and liver, reduced energy expenditure, and increased insulin resistance.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationInsulin suppression leads to an increase in plasma fatty acid and consequent absorption by liver and muscle tissue, creating intracellular lipotoxic environments that prevent the translocation of GLUT4 in skeletal muscles and adipose tissue.
“Insulin suppression leads to an increase in plasma fatty acid and consequent absorption by liver and muscle tissue, creating intracellular lipotoxic environments that prevent the translocation of GLUT4 in skeletal muscles and adipose tissue [104,105].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [104] Nayak, 2020, Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue, Physiol. Rep.
Not checked in the free run.
- cites [105] Goedeke, 2019, Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes, Ann. Rev. Pharmacol. Toxicol. source
Not checked in the free run.
May combine two claims.
PremisecitationMany studies point to a decrease in myostatin through physical exercise, with positive effects in combating insulin resistance and reducing fat accumulation and muscle hypertrophy.
“Many studies point to a decrease in myostatin through physical exercise, with positive effects in combating insulin resistance and reducing fat accumulation and muscle hypertrophy [95].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Leal, 2018, Physical exercise-induced myokines and muscle-adipose tissue crosstalk: A review of current knowledge and the implications for health and metabolic diseases, Front. Physiol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenANGPTL3 is expressed and released by the liver and works as a regulator of plasma triglyceride levels.
“ANGPTL3 is expressed and release by the liver and works as a regulator of plasma triglyceride levels, positively associated with glycemia, and insulin levels in patients with insulin resistance.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTogether, these cytokines induced in a healthy environment optimize the secretion and action of insulin, favor energy expenditure, reduce the storage of visceral fat, and stimulate polarization of MφM2 and reduction in Toll-like receptors (TLRs), decreasing the inflammatory pattern.
“Together, these cytokines induced in a healthy environment optimize the secretion and action of insulin; favor energy expenditure; reduce the storage of visceral fat; and, consequently, stimulate polarization of MϕM2 and reduction in Toll-like receptors (TLRs), decreasing the inflammatory pattern [11,102].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
- cites [102] Gannar, 2018, Myokines, physical activity, insulin resistance and autoimmune diseases, Immunol. Lett. source
Not checked in the free run.
May combine two claims.
PremisecitationMyostatin, TNF-α, leptin, resistin, chemerin, fetuin-A, and other cytokines build an inflammatory and oxidative stress scenario from the polarization of macrophages M1 in adipose tissue, production of reactive oxygen species, decreased insulin action, and release of FFA in plasma.
“Thus, myostatin, TNF-α, leptin, resistin, chemerin, fetuin-A, and other cytokines build an inflammatory and oxidative stress scenario from the polarization of macrophages (M ϕ) M1 in adipose tissue, production of reactive oxygen species, decreased insulin action, and release of FFA in plasma [11].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
PremisecitationIn obesity, leptin resistance caused by hyperleptinemia can limit muscle fatty acid oxidation and reduce lipolysis of adipose tissue.
“In obesity, leptin resistance caused by hyperleptinemia can limit muscle fatty acid oxidation and reduce lipolysis of adipose tissue.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [99] Batsis, 2018, Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies, Nat. Rev. Endocrinol. source
Not checked in the free run.
- cites [100] Hirschfeld, 2017, Osteosarcopenia: Where bone, muscle, and fat collide, Osteopor. Int. source
Not checked in the free run.
May combine two claims.
Premisenone givenMyostatin levels are increased with physical inactivity and high levels of fat mass.
“Present at the origin of several metabolic disorders, myostatin has negative effects on metabolism, and its levels are increased with physical inactivity and high levels of fat mass.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDeregulation of the secretion and production of adipokines and myokines contributes to excess adiposity and favors insulin resistance.
“An important contribution to excess adiposity and favoring insulin resistance is the deregulation of the secretion and production of adipokines and myokines [96].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] Becerril, 2017, Crosstalk between adipokines and myokines in fat browning, Acta Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationMyostatin promotes the release of inflammatory adipokines and hepatokines while inhibiting the release of myokines and other anti-inflammatory and antioxidant organokines.
“In parallel, myostatin promotes the state of obesity, sarcopenia, and sarcopenic obesity, which promotes the release of inflammatory adipokines and hepatokines while inhibiting the release of myokines and other anti-inflammatory and antioxidant organokines [14].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Oh, K.J., Lee, D.S., Kim, W.K., Han, B.S., Lee, S.C., and Bae, K.H. (2016). Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int. J. Mol. Sci., 18. source
Not checked in the free run.
May combine two claims.
PremisecitationDisproportionate release of pro-inflammatory adipokines and reduction in lipolysis are simultaneous with insulin resistance, which plays a substantial role in the development of DM2.
“Studies indicate that the disproportionate release of pro-inflammatory adipokines and the reduction in lipolysis are simultaneous with insulin resistance, which plays a substantial role in the development of DM2.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [104] Nayak, 2020, Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue, Physiol. Rep.
Not checked in the free run.
- cites [105] Goedeke, 2019, Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes, Ann. Rev. Pharmacol. Toxicol. source
Not checked in the free run.
May combine two claims.
PremisecitationTsukushi is an inducible hepatokine associated with the regulation of energy expenditure and is associated with obesity, NAFLD, and NASH.
“Tsukushi representes an inducible hepatokine associated with the regulation of energy expenditure and is mightily associated with obesity, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [78] Mouchiroud, 2019, The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis, JCI Insight source
Not checked in the free run.
- cites [88] Potthoff, 2021, Hepatokines and metabolism: Deciphering communication from the liver, Mol. Metab. source
Not checked in the free run.
- cites [89] Huang, 2021, Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer, Aging source
Not checked in the free run.
May combine two claims.
PremisecitationHyperglycemia contributes to the production of advanced glycation end products (AGEs), which, together with reactive oxygen species, cause endothelial damage.
“Hyperglycemia contributes to the production of advanced glycation end products (AGES), which, together with reactive oxygen species, cause endothelial damage, while adhesion molecules and immune cells are attracted to the vascular bed [94].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Castillo, 2020, Serum irisin levels, endothelial dysfunction, and inflammation in pediatric patients with type 2 diabetes mellitus and metabolic syndrome, J. Diab. Res.
Not checked in the free run.
May combine two claims.
PremisecitationMyostatin is elevated in pro-inflammatory environments, sharing space with pro-inflammatory organokines such as TNF-α, IL-1, resistin, chemerin, and others.
“Thus, myostatin is elevated in pro-inflammatory environments, sharing space with pro-inflammatory organokines such as TNF-α, IL-1, resistin, chemerin, and others [92].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Li, 2017, Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue, Cytokine Growth Factor Rev. source
Not checked in the free run.
May combine two claims.
PremisecitationAdropin is considered a protective factor of the endothelium, which increases the synthesis of nitric oxide (NO) due to the activation of eNOS.
“Therefore, adropin is considered a protective factor of the endothelium, which increases the synthesis of nitric oxide (NO) due to the activation of eNOS.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Mushala, 2021, Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism, Am. J. Physiol. Circ. Physiol. source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenThe released organokines lead to numerous metabolic and physiological effects that can be harmful or beneficial to the body.
“In this sense, the released organokines lead to numerous metabolic and physiological effects that can be harmful or beneficial to the body.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThey identified a less atherogenic apolipoprotein profile, reducing cardiovascular risks and promoting improvements in body weight and adiponectin levels.
“It was also shown that they identified a less atherogenic apolipoprotein profile, reducing cardiovascular risks and promoting improvements in body weight and adiponectin levels [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Meex, 2017, Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance, Nat. Rev. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationIn clinical studies, patients with DM2 treated with the FGF21 analog LY2405319 showed a reduction in LDL cholesterol and triglycerides, an increase in HDL cholesterol, and an improvement in insulin during fasting.
“In clinical studies, patients who had DM 2 were treated with concentrations of FGF21 (with the analog LY2405319), and they showed a reduction in low-density lipoprotein (LDL) cholesterol and triglycerides, an increase in high-density lipoprotein (HDL) cholesterol, and an improvement in insulin during periods of fasting [75].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Ennequin, 2019, Role of exercise-induced hepatokines in metabolic disorders, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationFGF21 controls insulin sensitivity by improving fat oxidation in the muscle, de novo lipogenesis (DNL) in the liver, and thermogenesis in WAT and BAT.
“FGF21 controls insulin sensitivity by improving fat oxidation in the muscle, de novo lipogenesis (DNL) in the liver, and thermogenesis in WAT and BAT.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [106] Degirolamo, 2016, Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23, Nat. Rev. Drug Disc. source
Not checked in the free run.
- cites [107] Keipert, 2020, Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?, Front. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationFGF21, when working as a hepatokine, acts as a beta-oxidation regulator and decreases lipogenesis in the liver, especially when it increases in the post-exercise period.
“In the same way that FGF21 is classified as myokine and adipokine, when working as an hepatokine, it acts as a beta-oxidation regulator and decreases lipogenesis in the liver, especially when it increases in the post-exercise period [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationObesity, insulin resistance, and inflammation are risk factors for several metabolic disorders.
“It is well known that obesity, insulin resistance, and inflammation are risk factors for several metabolic disorders [108].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Lee, 2018, Obesity-induced insulin resistance and macrophage infiltration of the adipose tissue: A vicious cycle, J. Diabetes Investig. source
Not checked in the free run.
May combine two claims.
Interpretationnone givenThe adipose, muscular, and hepatic tissues release several molecules that communicate through crosstalk and are capable of being biomarkers of homeostatic disorders.
“The adipose, muscular, and hepatic tissues release several molecules that communicate through crosstalk and are capable of being biomarkers of homeostatic disorders, and they can play roles as potential therapeutic targets that can assist in methods of diagnosing, prognosis, and perhaps future treatments of metabolic syndrome and CVD.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe release and complex interaction of these organokines depend on numerous factors, such as sedentary lifestyle and obesity.
“The release and complex interaction of these organokines depend on numerous factors, such as the sedentary lifestyle and obesity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPlasma levels of adropin increase with physical training and culminate with the suppression of atherosclerosis due to the regulation of monocyte differentiation.
“As a result, plasma levels of adropin increase with physical training and culminate with the suppression of atherosclerosis due to the regulation of monocyte differentiation, precisely its anti-inflammatory type.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Mushala, 2021, Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism, Am. J. Physiol. Circ. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationCirculating follistatin is elevated in patients with DM2 and generally correlates with insulin resistance markers, such as fasting glucose, glycated hemoglobin, and 2-h glucose during an oral glucose tolerance test.
“However, circulating follistatin was elevated in patients with DM2 and generally correlates with insulin resistance markers, such as fasting glucose, glycated hemoglobin, and 2-h glucose during an oral glucose tolerance test [111].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Hansen, 2016, Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio, J. Clin. Endocrinol. Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationAdropin levels decreased in patients with NASH and were negatively related to serum levels of alanine transaminase, aspartate aminotransferase, and gamma glutamyl transpeptidase.
“On the other hand, a case–control study showed that adropin levels decreased in patients with NASH and were negatively related to serum levels of alanine transaminase, aspartate aminotransferase, and gamma glutamyl transpeptidase.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] Chen, X., Sun, X., Shen, T., Chen, Q., Chen, S., Pang, J., Mi, J., Tang, Y., You, Y., and Xu, H. (2020). Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radic. Biol. Med., 160. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningUnderstanding how myokines, adipokines, and hepatokines interact can open up new paths in addressing metabolic problems, such as resistance to insulin and the development of diabetes, obesity, metabolic syndrome, and its repercussions.
“The understanding of how myokines, adipokines, and hepatokines interact can open up new paths in addressing metabolic problems, such as resistance to the action of insulin and the development of diabetes, obesity, metabolic syndrome, and its countless repercussions in the body, such as cardiovascular diseases.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationAdropin regulates plaque stability and vascular elasticity.
“In this scenario, it was also observed that adropin increases fibronectin and elastin expression in vascular smooth muscle cells (VSMCs) by overloading the PI3K-Akt pathway, thus assuming that adropin regulates plaque stability and elasticity vascular [112].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Mushala, 2021, Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism, Am. J. Physiol. Circ. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationFetuin-B negatively impacts metabolism because its serum level is higher in patients with coronary artery disease, especially in those with acute coronary syndrome.
“Finally, fetuin-B also negatively impacts metabolism because its serum level is higher in patients with coronary artery disease, especially in those with the acute coronary syndrome, and it still positively correlates with LDL-c levels [114].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Zhu, 2017, Increased serum levels of fetuin B in patients with coronary artery disease, Endocrine source
Not checked in the free run.
May combine two claims.
PremisecitationAdropin is expressed in endothelial cells and promotes proliferation, migration, formation of the capillary tube, attenuation of vascular permeability, and TNF-α-induced apoptosis.
“It is expressed in endothelial cells and promotes essential functions, such as proliferation, migration, and formation of the capillary tube, together with attenuation of vascular permeability and TNF-α-induced apoptosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Mushala, 2021, Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism, Am. J. Physiol. Circ. Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationWhen activated by exercise, follistatin inactivates myostatin and inhibits its pro-inflammatory effects, cooperating with lipolysis in WAT.
“When activated by exercise, follistatin inactivates myostatin and, therefore, inhibits its pro-inflammatory effects, consequently cooperating with lipolysis in WAT.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients, 12. source
Not checked in the free run.
May combine two claims.
PremisecitationThese hepatokines are usually elevated when associated with these pathologies and contribute to a state of systemic inflammation.
“They are usually elevated when associated with these pathologies and contribute to a state of systemic inflammation [88].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Potthoff, 2021, Hepatokines and metabolism: Deciphering communication from the liver, Mol. Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThese molecules can play roles as potential therapeutic targets that can assist in methods of diagnosing, prognosis, and perhaps future treatments of metabolic syndrome and CVD.
“The adipose, muscular, and hepatic tissues release several molecules that communicate through crosstalk and are capable of being biomarkers of homeostatic disorders, and they can play roles as potential therapeutic targets that can assist in methods of diagnosing, prognosis, and perhaps future treatments of metabolic syndrome and CVD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOverweight individuals secrete more pro-inflammatory adipokines, leading to an impaired immune response and greater susceptibility to inflammatory and infectious diseases.
“Overweight individuals secrete more pro-inflammatory adipokines, leading to an impaired immune response and greater susceptibility to inflammatory and infectious diseases [109].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] Soares, 2020, The role of adipokines in the Immunology of obesity, Res. Soc. Dev. source
Not checked in the free run.
The paper relies on this without support.
Adipose, skeletal muscle, and hepatic tissues are the main endocrine organs that produce adipokines, myokines, and hepatokines.
“Adipose, skeletal, and hepatic muscle tissues are the main endocrine organs that produce adipokines, myokines, and hepatokines.”
The paper relies on this without support.
These biomarkers can be harmful or beneficial and perform crosstalk through endocrine, paracrine, and autocrine pathways.
“These biomarkers can be harmful or beneficial to an organism and still perform crosstalk, acting through the endocrine, paracrine, and autocrine pathways.”
The paper relies on this without support.
Many organokines are secreted by all three tissues.
“Moreover, many organokines are secreted by all three tissues.”
The paper relies on this without support.
No review has shown a comprehensive overview of crosstalk among these organokines with focus on insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease.
“To the best of our knowledge, no review has shown a comprehensive overview of crosstalk or these organokines with focus on insulin resistance, diabetes, metabolic syndrome, and CVD.”
The paper relies on this without support.
Overweight individuals secrete more pro-inflammatory adipokines than healthy-weight individuals, leading to impaired immune response and greater susceptibility to inflammatory and infectious diseases.
“Overweight individuals secrete more pro-inflammatory adipokines than those of a healthy weight, leading to an impaired immune response and greater susceptibility to inflammatory and infectious diseases.”
The paper relies on this without support.
Myostatin is elevated in pro-inflammatory environments and co-occurs with pro-inflammatory organokines such as TNF-alpha, IL-1, resistin, and chemerin.
“Myostatin is elevated in pro-inflammatory environments, sharing space with pro-inflammatory organokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), resistin, and chemerin.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fetuin-A induces a pro-inflammatory milieu by polarizing M1 macrophages in WAT, generating ROS and reducing insulin sensitivity, which combined with other pro-inflammatory cytokines causes the development of sarcopenia.
“Fetuin-A, a systemic calcification inhibitor, induces a pro-inflammatory milieu by polarizing M1 macrophages in WAT, generating ROS and reducing insulin sensitivity, which combined with other pro-inflammatory cytokines causes the development of sarcopenia [122,123,124,125].”
From Exerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis (2025) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
FGF21 is said to both increase and decrease adipose-tissue lipolysis
MinorThe adipokine section attributes lipolysis to FGF21 in white adipose tissue, while the hepatokine section says FGF21 decreases lipolysis in adipose tissue. The text does not explain the opposing effects.
“In humans, FGF21 is responsible for the browning of WAT, activation of brown adipocytes, and lipolysis.”
“in the adipose tissue, FGF21 decreases lipolysis in vivo and in vitro”
Pro-inflammatory organokines are listed as anti-inflammatory
MinorThe exercise section lists TNF-α, resistin, chemerin, and fetuin-A among anti-inflammatory organokines. Elsewhere, the paper describes these same substances as contributing to an inflammatory and oxidative-stress scenario.
“the predominance of the secretion of anti-inflammatory myokines, adipokines, and hepatokines, such as irisin, IL-6, IL -15, myonectin, adiponectin, FGF21 (which mitigate the harmful effects of myostatin), TNF-α, resistin, chemerin, fetuin-A, and other cytokines [101].”
“myostatin, TNF-α, leptin, resistin, chemerin, fetuin-A, and other cytokines build an inflammatory and oxidative stress scenario”
Cites
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998 · see citing works
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · cited 1× · see citing works
“physical exercise and aggravated by an unhealthy lifestyle, as the pro-inflammatory state results in crosstalk that exacerbates the disease’s progression [99,100].”
BackgroundPhysical activity and muscle-brain crosstalk
Pedersen, B. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0174-x · Cited by 772 · see citing works
The endocrine function of adipose tissues in health and cardiometabolic disease
Scheja, L., & Heeren, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0230-6 · Cited by 663 · see citing works
Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · see citing works
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631 · see citing works
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591 · see citing works
Osteosarcopenia: where bone, muscle, and fat collide
Hirschfeld, H. P., Kinsella, R., & Duque, G. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4151-8 · Cited by 534 · see citing works
Muscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines
Kirk, B., Feehan, J., Lombardi, G., & Duque, G. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00599-y · Cited by 510 · see citing works
Leptin in the interplay of inflammation, metabolism and immune system disorders
Abella, V., Scotece, M., Conde, J., Pino, J., González-Gay, M. Á., Gómez-Reino, J. J., Mera, A., Lago, F., Gómez, R., & Gualillo, O. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.209 · Cited by 497 · see citing works
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., de Oliveira, G. M. M., Simão, A. F. L., Dutra, Ó. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R., Giuliano, I. D. C. B., Filho, A. C. D. A., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 469 · see citing works
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.9 · Cited by 424 · see citing works
Leal, L. G., Lopes, M. A., & Batista, M. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01307 · Cited by 382 · cited 1× · see citing works
“Many studies point to a decrease in myostatin through physical exercise, with positive effects in combating insulin resistance and reducing fat accumulation and muscle hypertrophy [95].”
BackgroundAsprosin is a centrally acting orexigenic hormone
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J. C., Romere, C., Saha, P. K., Lee, M. E., Phillips, K. J., Jain, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4432 · Cited by 357 · see citing works
Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Alloubani, A., Nimer, R. M., & Samara, R. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16999201210200342 · Cited by 352 · see citing works
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335 · see citing works
Altered nutrition behavior during COVID-19 pandemic lockdown in young adults
Huber, B. C., Steffen, J., Schlichtiger, J., & Brunner, S. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02435-6 · Cited by 290 · see citing works
Myokines and Adipokines: Involvement in the Crosstalk between Skeletal Muscle and Adipose Tissue
Li, F., Li, Y., Duan, Y., Hu, C.-A. A., Tang, Y., & Yin, Y. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.003 · Cited by 288 · see citing works
Cytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282 · see citing works
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · cited 11× · see citing works
“It also stimulates insulin release by increasing the expression of the glucagon-1-like peptide (GLP-1) [11,59].”
BackgroundInfluentialMyokines: The endocrine coupling of skeletal muscle and bone
Gomarasca, M., Banfi, G., & Lombardi, G. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.010 · Cited by 274 · see citing works
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261 · see citing works
Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism
Meex, R. C., Hoy, A. J., Morris, A., Brown, R. D., Lo, J. C. Y., Burke, M., Goode, R. J. A., Kingwell, B. A., Kraakman, M. J., Febbraio, M. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.023 · Cited by 255 · see citing works
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · see citing works
Mechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Rosa, S. C. D. S., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 251 · see citing works
Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Polyzos, S. A., Aronis, K. N., Kountouras, J., Raptis, D. D., Vasiloglou, M. F., & Mantzoros, C. S. (2016) · Diabetologia · doi:10.1007/s00125-015-3769-3 · Cited by 248 · see citing works
Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210 · see citing works
Adipose Tissue-Derived Omentin-1 Function and Regulation
Watanabe, T., Watanabe‐Kominato, K., Takahashi, Y., Kojima, M., & Watanabe, R. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160043 · Cited by 210 · see citing works
Crosstalk between adipokines and myokines in fat browning
Rodrı́guez, A., Becerril, S., Ezquerro, S., Méndez-Giménez, L., & Frühbeck, G. (2016) · Acta Physiologica · doi:10.1111/apha.12686 · Cited by 192 · see citing works
Asprosin: A Novel Player in Metabolic Diseases
Yuan, M., Li, W., Zhu, Y., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00064 · Cited by 176 · see citing works
Myokines mediate the cross talk between skeletal muscle and other organs
Chen, W., Wang, L., You, W., & Shan, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30033 · Cited by 162 · see citing works
On the Run for Hippocampal PlasticityPreprint
Cooper, C. P., Moon, H. Y., & van Praag, H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029736 · Cited by 160 · see citing works
Misu, H., Takayama, H., Saito, Y., Mita, Y., Kikuchi, A., Ishii, K.-A., Chikamoto, K., Kanamori, T., Tajima, N., Lan, F., et al. (2017) · Nature Medicine · doi:10.1038/nm.4295 · Cited by 156 · see citing works
Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
Barbalho, S. M., Flato, U. A. P., Tofano, R. J., Goulart, R. D. A., Guiguer, E. L., Detregiachi, C. R. P., Buchaim, D. V., Araújo, A. C., Buchaim, R. L., Reina, F. T. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103607 · Cited by 156 · see citing works
Self-citationMoon, H.-S., Matarese, G., Brennan, A. M., Chamberland, J. P., Liu, X., Fiorenza, C. G., Mylvaganam, G. H., Abanni, L., Carbone, F., Williams, C. J., et al. (2011) · Diabetes · doi:10.2337/db10-1791 · Cited by 151 · see citing works
Fibroblast growth factor 21 and browning of white adipose tissue
Cuevas-Ramos, D., Mehta, R., & Aguilar-Salinas, C. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00037 · Cited by 149 · see citing works
Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio
Hansen, J. S., Rutti, S., Arous, C., Clemmesen, J. O., Secher, N. H., Drescher, A., Gonelle-Gispert, C., Halban, P. A., Pedersen, B. K., Weigert, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3668 · Cited by 125 · see citing works
Frithioff‐Bøjsøe, C., Lund, M. A. V., Lausten‐Thomsen, U., Hedley, P. L., Pedersen, O. B., Christiansen, M., Baker, J. L., Hansen, T. F., & Holm, J. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12964 · Cited by 123 · see citing works
Kwon, J. H., Moon, K. M., & Min, K.-W. (2020) · Healthcare · doi:10.3390/healthcare8040378 · Cited by 116 · see citing works
Hepatokines: unlocking the multi-organ network in metabolic diseases
Iroz, A., Couty, J.-P., & Postic, C. (2015) · Diabetologia · doi:10.1007/s00125-015-3634-4 · Cited by 111 · see citing works
Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1681 · Cited by 106 · see citing works
Wu, H.-T., Ou, H.-Y., Hung, H.-C., Su, Y.-C., Lu, F.-H., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2016) · Diabetologia · doi:10.1007/s00125-016-3991-7 · Cited by 96 · see citing works
Lei, X., Seldin, M. M., Little, H. C., Choy, N., Klonisch, T. C., & Wong, G. W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.766808 · Cited by 96 · see citing works
Hepatokines and non-alcoholic fatty liver disease
Lebensztejn, D. M., Flisiak-Jackiewicz, M., Białokoz-Kalinowska, I., Bobrus-Chociej, A., & Kowalska, I. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1252 · Cited by 90 · see citing works
Buechler, C., Haberl, E. M., Rein‐Fischboeck, L., & Aslanidis, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071392 · Cited by 84 · see citing works
Myokines, physical activity, insulin resistance and autoimmune diseases
Díaz, B. B., González, D. A., Gannar, F., Pérez, M. C. R., & de León, A. C. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.09.002 · Cited by 82 · see citing works
Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79 · cited 1× · see citing works
“It is secreted by skeletal muscle cells and is involved in the skeletal muscle hypertrophy and regulates muscle growth with the practice of physical exercise [63].”
BackgroundActivin E controls energy homeostasis in both Brown and white adipose tissues as a hepatokine
Hashimoto, O., Funaba, M., Sekiyama, K., Doi, S., Shindo, D., Satoh, R., Itoi, H., Oiwa, H., Morita, M., Suzuki, C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.008 · Cited by 77 · see citing works
Goedeke, L., Perry, R. J., & Shulman, G. I. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 76 · see citing works
Angptl8 mediates food-driven resetting of hepatic circadian clock in mice
Chen, S., Feng, M., Zhang, S., Dong, Z., Wang, Y., Zhang, W., & Liu, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11513-1 · Cited by 73 · see citing works
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis
Franco‐Trepat, E., Guillán‐Fresco, M., Alonso‐Pérez, A., Mora, A. J., Francisco, V., Gualillo, O., & Gómez, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081178 · Cited by 72 · see citing works
Myokines: a descriptive review
Barbalho, S. M., Neto, E. V. P., Goulart, R. D. Á., Bechara, M. D., Chagas, E. F. B., Audi, M., Campos, L. M. G., Guiguer, É. L., Buchaim, R. L., Buchaim, D. V., et al. (2020) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.20.10884-3 · Cited by 67 · see citing works
Self-citationVaspin suppresses cytokine-induced inflammation in 3T3-L1 adipocytes via inhibition of NFκB pathway
Zieger, K., Weiner, J., Krause, K., Schwarz, M., Kohn, M., Stumvoll, M., Blüher, M., & Heiker, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.022 · Cited by 65 · see citing works
Shen, X., Yang, L., Yan, S., Zheng, H., Liang, L., Cai, X., & Liao, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.014 · Cited by 63 · see citing works
The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
Choi, K. M. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.1 · Cited by 62 · see citing works
Barchetta, I., Cimini, F. A., Capoccia, D., De Gioannis, R., Porzia, A., Mainiero, F., Di Martino, M., Bertoccini, L., De Bernardinis, M., Leonetti, F., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00108 · Cited by 60 · see citing works
Gözel, N., & Kılınç, F. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0059 · Cited by 58 · see citing works
Hepatokines—A novel group of exercise factors
Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57 · see citing works
The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129492 · Cited by 57 · see citing works
The role of Asprosin in patients with dilated cardiomyopathy
Wen, M.-S., Wang, C.-Y., Yeh, J.-K., Chen, C.-C., Tsai, M.-L., Ho, M.-Y., Hung, K.-C., & Hsieh, I.-C. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01680-1 · Cited by 57 · see citing works
Adipokine Visfatin’s Role in Pathogenesis of Diabesity and Related Metabolic Derangements
Kumari, B., & Yadav, U. C. S. (2018) · Current Molecular Medicine · doi:10.2174/1566524018666180705114131 · Cited by 56 · see citing works
Role of Zinc in Zinc-α2-Glycoprotein Metabolism in Obesity: a Review of Literature
Severo, J. S., Morais, J. B. S., Beserra, J. B., dos Santos, L. R., Melo, S. R. D. S., de Sousa, G. S., Neto, E. M. D. M., Henriques, G. S., & Marreiro, D. D. N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01702-w · Cited by 55 · see citing works
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54 · see citing works
The role of myokines and adipokines in hypertension and hypertension-related complications
Chen, K., Zhou, M., Wang, X., Li, S., & Yang, D. (2019) · Hypertension Research · doi:10.1038/s41440-019-0266-y · Cited by 54 · see citing works
Adropin: A hepatokine modulator of vascular function and cardiac fuel metabolism
Mushala, B. A. S., & Scott, I. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00449.2020 · Cited by 53 · see citing works
Sugiyama, M., Kikuchi, A., Misu, H., Igawa, H., Ashihara, M., Kushima, Y., Honda, K., Suzuki, Y., Kawabe, Y., Kaneko, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194798 · Cited by 52 · see citing works
Perakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01056 · Cited by 52 · see citing works
Lee, C., & Lam, K. S. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12918 · Cited by 49 · see citing works
Sarcopenic obesity in fatty liver
Merli, M., Lattanzi, B., & Aprile, F. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000558 · Cited by 48 · see citing works
Alteration of physical activity during COVID-19 pandemic lockdown in young adults
Huber, B. C., Steffen, J., Schlichtiger, J., Graupe, T., Deuster, E., Strouvelle, V. P., Fischer, M., Maßberg, S., & Brunner, S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02591-7 · Cited by 48 · see citing works
Serum adropin level in patients with stable coronary artery disease
Zhao, L.-P., Xu, W.-T., Wang, L., You, T., Chan, S.-P., Zhao, X., & Yang, X.-J. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.03.008 · Cited by 46 · see citing works
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46 · see citing works
Hepatic chemerin <scp>mRNA</scp> expression is reduced in human nonalcoholic steatohepatitis
Pohl, R., Haberl, E. M., Rein‐Fischboeck, L., Zimny, S., Neumann, M., Aslanidis, C., Schacherer, D., Krautbauer, S., Eisinger, K., Weiss, T. S., et al. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12695 · Cited by 45 · see citing works
Secretomics to Discover Regulators in Diseases
Song, P., Kwon, Y., Joo, J., Kim, D.-G., & Yoon, J. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163893 · Cited by 44 · see citing works
Metabolic adaptations after bariatric surgery: Adipokines, myokines and hepatokines
Faramia, J., Ostinelli, G., Drolet-Labelle, V., Picard, F., & Tchernof, A. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.06.005 · Cited by 44 · see citing works
Vaspin promotes insulin sensitivity in elderly muscle and is upregulated in obesity
Nicholson, T. A., Church, C., Tsintzas, K., Jones, R., Breen, L., Davis, E. T., Baker, D. J., & Jones, S. W. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0528 · Cited by 43 · see citing works
Aoi, W., Hirano, N., Lassiter, D. G., Björnholm, M., Chibalin, A., Sakuma, K., Tanimura, Y., Mizushima, K., Takagi, T., Naito, Y., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900453r · Cited by 43 · see citing works
Korolczuk, A., & Bełtowski, J. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170124114524 · Cited by 42 · see citing works
Experimental Rodent Models of Cardiovascular Diseases
Jia, T., Wang, C., Han, Z., Wang, X., Ding, M., & Wang, Q. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.588075 · Cited by 42 · see citing works
Gholamrezayi, A., Mohamadinarab, M., Rahbarinejad, P., Fallah, S., Barez, S. R., Setayesh, L., Moradi, N., Fadaei, R., Chamani, E., & Tavakoli, T. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01404-6 · Cited by 41 · see citing works
Delgado, A. S. H., Roffe-Vazquez, D. N., González-Gil, A. M., Villarreal-Calderón, J. R., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Castillo, E. C., Silva‐Platas, C., García‐Rivas, G., & Elizondo‐Montemayor, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1949415 · Cited by 40 · see citing works
The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review
Byun, K., & Lee, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197184 · Cited by 38 · see citing works
Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice
Chikamoto, K., Misu, H., Takayama, H., Kikuchi, A., Ishii, K.-A., Lan, F., Takata, N., Tajima-Shirasaki, N., Takeshita, Y., Tsugane, H., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.117 · Cited by 37 · see citing works
Fu, J., Li, Y., Esangbedo, I. C., Li, G., Feng, D., Li, L., Xu, L., Han, L., Li, M., Li, C., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009169 · Cited by 37 · see citing works
Sato, K., Shirai, R., Yamaguchi, M., Yamashita, T., Shibata, K., Okano, T., Mori, Y., Matsuyama, T.-A., Ishibashi-Ueda, H., Hirano, T., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061732 · Cited by 36 · see citing works
Sodium rutin extends lifespan and health span in mice including positive impacts on liver health
Li, S., Li, J., Pan, R., Cheng, J., Cui, Q., Chen, J., & Yuan, Z. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15410 · Cited by 36 · see citing works
Increased serum levels of fetuin B in patients with coronary artery disease
Zhu, K., Wang, Y., Shu, P., Zhou, Q., Zhu, J., Zhou, W., Du, C., Xu, C., Liu, X., & Tang, L. (2017) · Endocrine · doi:10.1007/s12020-017-1387-1 · Cited by 33 · see citing works
Serum irisin, adropin, and preptin in obese patients 6 months after bariatric surgery
Glück, M., Glück, J., Wiewióra, M., Rogala, B., & Piecuch, J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03998-y · Cited by 31 · see citing works
Chen, X., Sun, X., Shen, T., Chen, Q., Chen, S., Pang, J., Mi, J., Tang, Y., You, Y., Xu, H., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.005 · Cited by 30 · see citing works
Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders
Kim, J. A., & Choi, K. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568800 · Cited by 30 · see citing works
Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30 · see citing works
Chan, Y. Y., Kuay, L. K., Omar, M. A., et al. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13977 · Cited by 30 · see citing works
Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
Horak, M., Kuruczová, D., Zlámal, F., Tomandl, J., & Vašků, J. B. (2018) · Disease Markers · doi:10.1155/2018/4140815 · Cited by 28 · see citing works
Lin, M., Liu, Z., Liu, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1023 · Cited by 28 · see citing works
Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?
Klein Hazebroek, M., & Keipert, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00389 · Cited by 27 · see citing works
Understanding Obesity-Related Cardiovascular Disease: It’s All About Balance
Zarzour, A., Kim, H. W., & Weintraub, N. L. (2018) · Circulation · doi:10.1161/circulationaha.118.034454 · Cited by 26 · see citing works
Mukherjee, S., Choi, M. J., Kim, S. W., & Yun, J. W. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110757 · Cited by 24 · see citing works
Low serum ZAG levels correlate with determinants of the metabolic syndrome in Chinese subjects
Wang, L., Liu, M., Ning, D., Zhu, H., Shan, G., Wang, D., Ping, B., Yu, Y., Yang, H., Yan, K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00154 · Cited by 21 · see citing works
Park, C. Y., Moon, J., Jo, G., Lee, J., Kim, O. Y., Oh, H., Lim, H., & Shin, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-36581-z · Cited by 17 · see citing works
Ouerghi, N., Ben Fradj, M. K., Talbi, E., Bezrati, I., Feki, M., & Bouassida, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155170 · Cited by 17 · see citing works
Sofra, X., & Badami, S. (2020) · Health · doi:10.4236/health.2020.128076 · Cited by 17 · see citing works
Resistin is co-secreted with adiponectin in white mouse adipocytes
Musovic, S., Shrestha, M. M., Komai, A. M., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.013 · Cited by 17 · see citing works
Huang, H., Zhang, D., Fu, J., Zhao, L., Li, D., Sun, H., Liu, X., Xu, J., Tian, T., Zhang, L., et al. (2021) · Aging · doi:10.18632/aging.202403 · Cited by 17 · see citing works
Pathophysiological significance of hepatokine overproduction in type 2 diabetes
Misu, H. (2018) · Diabetology International · doi:10.1007/s13340-018-0368-9 · Cited by 16 · see citing works
Wang, B., Pan, Y., Yang, G., et al. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.11.002 · Cited by 16 · see citing works
Mapping risk of ischemic heart disease using machine learning in a Brazilian state
Bergamini, M., Iora, P. H., Rocha, T. A. H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243558 · Cited by 16 · see citing works
Choi, S.-K., Kwon, Y., Byeon, S., Haam, C. E., & Lee, Y.-H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230227 · Cited by 15 · see citing works
Pazgan−Simon, M., Zuwała−Jagiełło, J., Kukla, M., Grzebyk, E., & Simon, K. A. (2020) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2020.99517 · Cited by 14 · see citing works
Çakırca, G., & Turgut, F. H. (2018) · Iranian Journal of Kidney Diseases · Cited by 12 · see citing works
Hou, G., Tang, Y., Ren, L., Guan, Y., Hou, X., & Song, G. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1621239 · Cited by 11 · see citing works
Mikołajczak, A., Oświęcimska, J. M., Świętochowska, E., et al. (2017) · PubMed · Cited by 10 · see citing works
GOZEL, N., Oral, K., Ozdemir, F. A., Onalan, E., Kuloglu, T., Aydın, S., Karataş, A., & Kılınç, F. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0017 · Cited by 6 · see citing works
Fetuin-a expression profile in mouse and human adipose tissue
Khadir, A., Kavalakatt, S., Madhu, D., & Tiss, A. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01225-7 · Cited by 4 · see citing works
Zhang, W., Qiao, Y., Qi, F., Shen, Q., Zhao, R., & Yang, X. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1186-0649 · Cited by 4 · see citing works
O Papel das Adipocinas na Imunologia da Obesidade
Soares, P. E. M., Ferreira, E. T. D. O., Mafra, G. C. D. S., et al. (2020) · Research Society and Development · doi:10.33448/rsd-v9i7.5095 · Cited by 4 · see citing works
Flagged first, then by citations
5 of the 120 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Sandhu, 2020, Cure of obesity in homeopathy: An approach to control a global epidemic, Tantian Univ. J. Homoeopath. Med. Sci., 1, 17
- Oliveira, 2019, Atualização da diretriz de prevenção cardiovascular da sociedade brasileira de cardiologia, Arq. Bras. Cardiol., 113, 787
Cited by
Sorted by citations
Pediatric obesity—Long‐term consequences and effect of weight loss
Marcus, C., Danielsson, P., & Hagman, E. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13547 · Cited by 267 · see citing works
Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H. R., & Gao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873699 · Cited by 260 · see citing works
Sandireddy, R., Sakthivel, S., Gupta, P., Behari, J., Tripathi, M., & Singh, B. K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1433857 · Cited by 229 · see citing works
Koceva, A., Herman, R., Janež, A., Rakuša, M., & Jensterle, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137342 · Cited by 167 · see citing works
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
Kitamura, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043219 · Cited by 142 · see citing works
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
Park, M., & Choi, K. M. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155577 · Cited by 106 · see citing works
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 125 · see citing works
Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K., & Jensen, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.737709 · Cited by 112 · see citing works
“Exactly how exercise improves NAFLD is not completely understood (van der Windt et al., 2018); however, complex crosstalk between adipokines, hepatokines, and myokines has been suggested to play a central role in this improvement (de Oliveira Dos Santos et al., 2021).”
BackgroundPanax ginseng and aging related disorders: A systematic review
Zanuso, B. D. O., dos Santos, A. R. D. O., Miola, V. F. B., Campos, L. M. G., Spilla, C. S. G., & Barbalho, S. M. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111731 · Cited by 106 · see citing works
Self-citationOrgan crosstalk and dysfunction in sepsis
Borges, A., & Bento, L. F. N. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01377-0 · Cited by 93 · see citing works
Jouy, S. H., Mohan, S., Scichilone, G., Mostafa, A., & Mahmoud, A. M. (2024) · Biomedicines · doi:10.3390/biomedicines12092129 · Cited by 92 · see citing works
Cól, J. P. D., de Lima, E. P., Pompeu, F. M., Araújo, A. C., Goulart, R. D. Á., Bechara, M. D., Laurindo, L. F., Méndez‐Sánchez, N., & Barbalho, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073694 · Cited by 76 · see citing works
Self-citationMittenbühler, M. J., Jedrychowski, M. P., Vranken, J. G. V., Sprenger, H., Wilensky, S. E., Dumesic, P. A., Sun, Y., Tartaglia, A., Laznik-Bogoslavski, D., Mu, A., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.014 · Cited by 66 · see citing works
de Lima, E. P., Moretti, R. C., Pomini, K. T., Laurindo, L. F., Sloan, K. P., Sloan, L. A., de Castro, M. V. M., Baldi, E., Ferraz, B. F. R., Pereira, E. D. S. B. M., et al. (2024) · Biology · doi:10.3390/biology13070519 · Cited by 71 · see citing works
Self-citationInsights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review
Mellem, R. H., Girotto, O. S., Marques, E. B., Laurindo, L. F., Grippa, P. C., Mendes, C. G., Garcia, L. N. H., Bechara, M. D., Barbalho, S. M., Sinatora, R. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010136 · Cited by 67 · see citing works
Self-citationIglesias, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134490 · Cited by 76 · see citing works
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58 · see citing works
Minniti, G., Pescinini-Salzedas, L. M., Minniti, G. A. D. S., Laurindo, L. F., Barbalho, S. M., Sinatora, R. V., Sloan, L. A., Haber, R. S. D. A., Araújo, A. C., Quesada, K. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113452 · Cited by 52 · see citing works
Self-citationNon-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
dos Santos, J. P. M., de Maio, M. C., Lemes, M. A., Laurindo, L. F., Haber, J. F. D. S., Bechara, M. D., do Prado, P. S., Rauen, E. C., Costa, F., Pereira, B. C. D. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010498 · Cited by 47 · see citing works
Self-citationAlves, M. D. D. J., Silva, D. D. S., Pereira, E. V. M., Pereira, D. D., Fernandes, M. S. D. S., Santos, D. F. C., Oliveira, D. P. M., Souza, L. M. V., Aidar, F. J., & de Souza, R. F. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.838069 · Cited by 45 · see citing works
Adipokines in glucose and lipid metabolism
Wang, X., Zhang, S., & Li, Z. (2023) · Adipocyte · doi:10.1080/21623945.2023.2202976 · Cited by 50 · see citing works
Barbalho, S. M., Méndez‐Sánchez, N., & Laurindo, L. F. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115871 · Cited by 46 · see citing works
Self-citationZamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 42 · see citing works
Porflitt-Rodríguez, M., Guzmán-Arriagada, V., Sandoval-Valderrama, R., Tam, C. S., Pavicic, F., Ehrenfeld, P., & Martínez-Huenchullán, S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155137 · Cited by 42 · see citing works
Roles of Insect Oenocytes in Physiology and Their Relevance to Human Metabolic Diseases
Huang, K., Liu, Y., & Perrimon, N. (2022) · Frontiers in Insect Science · doi:10.3389/finsc.2022.859847 · Cited by 39 · see citing works
Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2
Perrotta, F., Scialò, F., Mallardo, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021131 · Cited by 38 · see citing works
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y.-A., Wu, T., Chen, C.-H., & Lu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137092 · Cited by 37 · see citing works
Interorgan communication networks in the kidney–lung axis
Komaru, Y., Bai, Y. Z., Kreisel, D., & Herrlich, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00760-7 · Cited by 40 · see citing works
Li, S., Zou, T., Chen, J., Li, J., & You, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.033 · Cited by 37 · see citing works
Organokines in Rheumatoid Arthritis: A Critical Review
Laurindo, L. F., de Maio, M. C., Barbalho, S. M., Guiguer, É. L., Araújo, A. C., Goulart, R. D. Á., Flato, U. A. P., Baldi, E., Detregiachi, C. R. P., Haber, J. F. D. S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116193 · Cited by 37 · see citing works
Self-citationSarcopenia in Chronic Liver Disease: A Metabolic Perspective
Kumar, R. K., Prakash, S. S., Priyadarshi, R. N., & Anand, U. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00239 · Cited by 35 · see citing works
Relationship of Inflammatory Markers and Metabolic Syndrome in Postmenopausal Women
Sinatora, R. V., Chagas, E. F. B., Mattera, F. O. P., Mellem, L. J., dos Santos, A. R. D. O., Pereira, L. P., Aranão, A. L. D. C., Guiguer, É. L., Araújo, A. C., Haber, J. F. D. S., et al. (2022) · Metabolites · doi:10.3390/metabo12010073 · Cited by 35 · see citing works
Self-citationHepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Milani, I., Codini, M., Guarisco, G., Chinucci, M., Gaita, C., Leonetti, F., & Capoccia, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910795 · Cited by 33 · see citing works
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Wang, Y., Wu, L.-L., Qi, X.-Y., Wang, Y.-Y., Liao, Z., Liu, J., & Xiao, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.013 · Cited by 35 · see citing works
Targeting gut-liver axis by dietary lignans ameliorate obesity: evidences and mechanisms
Chu, Z., Hu, Z., Luo, Y., Zhou, Y., Yang, F., & Luo, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272269 · Cited by 34 · see citing works
Pelczyńska, M., Miller‐Kasprzak, E., Piątkowski, M., Mazurek, R., Klause, M., Suchecka, A., Bucoń, M., & Bogdański, P. (2023) · Antioxidants · doi:10.3390/antiox12122046 · Cited by 31 · see citing works
Is dynapenic abdominal obesity a risk factor for cardiovascular mortality? A competing risk analysis
Ramírez, P. C., de Oliveira, D. C., Máximo, R. D. O., de Souza, A. F., Luiz, M. M., Delinocente, M. L. B., Steptoe, A., de Oliveira, C. M., & Alexandre, T. D. S. (2022) · Age and Ageing · doi:10.1093/ageing/afac301 · Cited by 31 · see citing works
Hepatogenous diabetes: Knowledge, evidence, and skepticism
Kumar, R. K., García‐Compeán, D., & Maji, T. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1291 · Cited by 30 · see citing works
Myokines: Crosstalk and Consequences on Liver Physiopathology
Dumond, A., Potier, J.-B., Pinget, M., & Bouzakri, K. (2023) · Nutrients · doi:10.3390/nu15071729 · Cited by 29 · see citing works
Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance
Uchiyama, T., Ota, H., Ohbayashi, C., & Takasawa, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312898 · Cited by 29 · see citing works
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
Gallorini, M., Carradori, S., Panieri, E., Sova, M., & Saso, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0213 · Cited by 29 · see citing works
Iacob, S. A., & Iacob, D. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814209 · Cited by 28 · see citing works
Zhen, Q., Liang, Q., Wang, H., Zheng, Y., Lu, Z., Bian, C., Zhao, X., & Guo, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1118925 · Cited by 27 · see citing works
Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
Lőrincz, H., Somodi, S., Ratku, B., Harangi, M., & Paragh, G. (2023) · Metabolites · doi:10.3390/metabo13020270 · Cited by 25 · see citing works
Jain, P., Jain, A., Deshmukh, R., Samal, P. K., Satapathy, T., & Ajazuddin, M. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102584 · Cited by 25 · see citing works
Organokines in COVID-19: A Systematic Review
Barbalho, S., Minniti, G., Miola, V. F. B., Haber, J. F. D. S., Bueno, P. C. D. S., Haber, L. S. D. A., Girio, R. J., Detregiachi, C. R. P., Dall’Antonia, C. T., Rodrigues, V. D., et al. (2023) · Cells · doi:10.3390/cells12101349 · Cited by 22 · see citing works
Self-citationExerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis
Wang, J., Jia, D., Zhang, Z., & Wang, D. (2025) · Metabolites · doi:10.3390/metabo15010059 · Cited by 23 · see citing works
Juhász, I., Ujfalusi, S., Seres, I., et al. (2022) · Biomolecules · doi:10.3390/biom12010116 · Cited by 22 · see citing works
Wang, Y. Y., Wang, Y., Qi, X.-Y., Liao, Z., Mai, Y.-N., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839849 · Cited by 22 · see citing works
Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities
Wang, R., Sun, Q., Wu, X., Zhang, Y., Xing, X., Lin, K., Feng, Y., Wang, M., Wang, M., & Wang, Y. (2022) · Cells · doi:10.3390/cells11233735 · Cited by 22 · see citing works
Jiménez-Franco, A., Castañé, H., Martínez-Navidad, C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.12.002 · Cited by 20 · see citing works
The endocrine role of hepatokines: implications for human health and disease
Iglesias, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1663353 · Cited by 22 · see citing works
Peripheral Aβ acts as a negative modulator of insulin secretion
Shigemori, K., Nomura, S., Umeda, T., Takeda, S., & Tomiyama, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117723119 · Cited by 18 · see citing works
Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism
Li, S., Chen, J., Wei, P., Zou, T., & You, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316951 · Cited by 19 · see citing works
Cui, X., Liu, H., Liu, Y., Yu, Z., Wang, D., Wei, W., & Wang, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1665708 · Cited by 22 · see citing works
NF-κB-Inducing Kinase Provokes Insulin Resistance in Skeletal Muscle of Obese Mice
Chen, X., Liu, Z., Liu, W., Wang, S. F., Jiang, R., Hu, K., Sheng, L., Xu, G., Kou, X., & Song, Y. (2023) · Inflammation · doi:10.1007/s10753-023-01820-7 · Cited by 19 · see citing works
Sierawska, O., & Sawczuk, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417287 · Cited by 17 · see citing works
Mechanisms of interorgan crosstalk in health and disease
Herrlich, A., Kefaloyianni, E., & Rose‐John, S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14313 · Cited by 15 · see citing works
Adropin may regulate corpus luteum formation and its function in adult mouse ovary
Maurya, S., Tripathi, S., Arora, T. K., & Singh, A. K. (2023) · HORMONES · doi:10.1007/s42000-023-00476-0 · Cited by 15 · see citing works
Seetharaman, R., Pawar, S. R., & Advani, M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15100 · Cited by 14 · see citing works
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Ishibashi, C., Nakanishi, K., Nishida, M., Shinomiya, H., Shinzawa, M., Kanayama, D., Yamamoto, R., Kudo, T., Nagatomo, I., & Yamauchi‐Takihara, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-79534-5 · Cited by 13 · see citing works
Losasso, M. R., Parussolo, M. L. C., Silva, A. O., Direito, R., Quesada, K. R., Detregiachi, C. R. P., Bechara, M. D., Méndez‐Sánchez, N., Abenavoli, L., Araújo, A. C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104673 · Cited by 13 · see citing works
Self-citationKobayashi, Y., Eguchi, A., Imami, K., Tempaku, M., Izuoka, K., Takase, T., Kainuma, K., Nagao, M., Furuta, N., Iwasa, M., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02386-5 · Cited by 12 · see citing works
Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases
Lyu, J.-X., Guo, D., Song, Y.-C., Zhang, M.-R., Ge, F.-Q., Zhao, J., Zhu, H., & Hang, P. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2502056 · Cited by 13 · see citing works
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 13 · see citing works
Sinha, S., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.28762 · Cited by 13 · see citing works
Memelink, R. G., Njemini, R., Kuil, M. J. J. D. B., Wopereis, S., den Bosch, J. D. V., Schoufour, J. D., Tieland, M., Weijs, P. J. M., & Bautmans, I. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112410 · Cited by 11 · see citing works
Hénin, G., Loumaye, A., Deldicque, L., Leclercq, I. A., & Lanthier, N. (2024) · Liver International · doi:10.1111/liv.15938 · Cited by 12 · see citing works
Jóźwiak, B., Domin, R., Krzywicka, M., & Laudańska–Krzemińska, I. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05738-y · Cited by 12 · see citing works
Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
Su, X., Yang, D., Hu, Y., Yuan, Y., & Song, L. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0648 · Cited by 11 · see citing works
Herrera, I. R., Nogales, F., Díaz‐Castro, J., Moreno‐Fernández, J., Gallego‐López, M. D. C., Ochoa, J. J., Carreras, O., & Ojeda, M. L. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00983-z · Cited by 10 · see citing works
Herrera, I. R., Nogales, F., Gallego‐López, M. D. C., Díaz‐Castro, J., Carreras, O., & Ojeda, M. L. (2024) · Food & Function · doi:10.1039/d4fo01354a · Cited by 12 · see citing works
Stem cells and regenerative medicine in sport science
Stewart, C. E. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210014 · Cited by 10 · see citing works
Sarcopenia in the setting of nonalcoholic fatty liver
Arrese, M. A., Cabello‐Verrugio, C., Arab, J. P., Francisco Barrera, M., Baudrand, R. F., Guarda, F. J., Gul, I., & Cabrera, D. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.16 · Cited by 10 · see citing works
Faiz, H., Heiston, E. M., & Malin, S. K. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4618215 · Cited by 9 · see citing works
Menegucci, T., Chagas, E. F. B., Zanuso, B. D. O., Quesada, K. R., Haber, J. F. D. S., Zutin, T. L. M., Pimenta, L. F. S., Araújo, A. C., Guiguer, É. L., Detregiachi, C. R. P., et al. (2023) · Diseases · doi:10.3390/diseases11040125 · Cited by 10 · see citing works
Self-citationWhat is the disease burden from childhood and adolescent obesity?: a narrative review
Lee, E. B. (2024) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2024.00360 · Cited by 10 · see citing works
dos Santos, L. L., de Castro, J. B. P., Linhares, D. G., dos Santos, A. O. B., Cordeiro, L. D. S., Borba-Pinheiro, C. J., & Vale, R. G. D. S. (2023) · Retos · doi:10.47197/retos.v49.98939 · Cited by 11 · see citing works
Self-citationAbudalo, R. A., Alqudah, A. M., Qnais, E. Y., Athamneh, R. Y., Oqal, M. K., & Alnajjar, R. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e114863 · Cited by 9 · see citing works
Transcriptome Analysis of Multiple Metabolic Tissues in High-Salt Diet–Fed Mice
Mao, F., Wang, E., Xu, J., Lu, J., Yan, G., Fu, L., Jiao, Y., Wu, L., Liu, T., & Li, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.887843 · Cited by 9 · see citing works
Features of circumference sizes in women of different constitutional groups
Nuruev, M., Sakibaev, K. S., Dzholdosheva, G. T., et al. (2022) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12791 · Cited by 9 · see citing works
Hepatokines and their role in cardiohepatic interactions in heart failure
Shouman, W. A., Najmeddine, S., Sinno, L., Nehme, R. D., Ghawi, A. E., Ziade, J. A., Altara, R., Amin, G., Booz, G. W., & Zouein, F. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177356 · Cited by 8 · see citing works
Systemic and metabolic control of liver regeneration
Deng, Y., Zhao, Z., Sun, Y., & Ma, L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.008 · Cited by 9 · see citing works
Muskeltraining – ein universelles Medikament
Laube, W. (2021) · Manuelle Medizin · doi:10.1007/s00337-021-00801-x · Cited by 8 · see citing works
Lam, S., Lee, C., Fong, C. H.-Y., Wong, Y., Shiu, S. W. M., Mak, L., Yuen, M., Lam, K. S. L., & Tan, K. C. B. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad650 · Cited by 8 · see citing works
Youssef, S. R., Hassan, E. H., Morad, C. S., Elged, A. A. E., & El‐Gamal, R. A. E. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s327465 · Cited by 8 · see citing works
Barbalho, S. M., Laurindo, L. F., Valenti, V. E., Méndez‐Sánchez, N., Ramírez-Mejía, M. M., & Goulart, R. D. Á. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311547 · Cited by 7 · see citing works
Self-citationZhu, Q., Zhang, T., Cheang, I., Lu, X., Shi, M., Zhu, X., Liao, S., Gao, R., Li, X., & Yao, W. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06700-7 · Cited by 7 · see citing works
Lee, H., Kim, S. Y., & Lim, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109537 · Cited by 7 · see citing works
Erdem, N. B., Aksoy, E. K., Dikmen, D., Uçar, K., Ağaçdiken, A., Esgin, M. İ., & Göktaş, Z. (2024) · Medicine · doi:10.1097/md.0000000000037716 · Cited by 7 · see citing works
Ghaffary, E. M., Bjørklund, G., Bhat, R. S., & Mirmosayyeb, O. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103825 · Cited by 7 · see citing works
Adropin may promote insulin stimulated steroidogenesis and spermatogenesis in adult mice testes
Tripathi, S., Maurya, S., & Singh, A. K. (2023) · Journal of Experimental Zoology Part A Ecological and Integrative Physiology · doi:10.1002/jez.2763 · Cited by 7 · see citing works
Ward, K., Mulder, E. R., Frings‐Meuthen, P., O’Gorman, D. J., & Cooper, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1435448 · Cited by 7 · see citing works
Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle‐secreted factors
Sammut, M. J., Thorne, B. R., & Melling, C. W. J. (2025) · Obesity · doi:10.1002/oby.24223 · Cited by 7 · see citing works
Zakaria, A. Y., Badawi, R., Osama, H., Abdelrahman, M. A., & El-Kalaawy, A. M. (2025) · Pharmaceuticals · doi:10.3390/ph18050650 · Cited by 7 · see citing works
Role of immunity and inflammation in sarcopenic obesity
Ma, Y. F., Li, X., Lin, X., Zhang, K., & Leng, J. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110077 · Cited by 6 · see citing works
Systemic Inflammation Indices, Chemokines, and Metabolic Markers in Perimenopausal Women
Cybulska, A. M., Rachubińska, K., Grochans, E., Bosiacki, M., Simińska, D., Korbecki, J., Lubkowska, A., Pańczyk, M., Kuczyńska, M., & Schneider-Matyka, D. (2025) · Nutrients · doi:10.3390/nu17172885 · Cited by 8 · see citing works
Kim, J. S., Song, J., Choi, S., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1259292 · Cited by 6 · see citing works
Hirabara, S. M., Marzuca-Nassr, G. N., & Cury‐Boaventura, M. F. (2024) · Nutrients · doi:10.3390/nu16020293 · Cited by 6 · see citing works
Elfedawy, M. A. E. M., Elsebai, S. A. E. S., Tawfik, H. A. M., Youness, E. R., & Zaki, M. E. (2024) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2024.100438 · Cited by 6 · see citing works
- Authors
- de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., Mendes, C. G., Tofano, V. A. C., & dos Santos Haber, J. F.
- Affiliations
- Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho 1001, Marília 17525-902, São Paulo, Brazil
- Universidade de Marília (BR)
- Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marilia (UNIMAR), Avenida Hygino Muzzy Filho 1001, Marília 17525-902, São Paulo, Brazil
- Universidade de São Paulo (BR)
- Corresponding author
- Barbalho, Sandra Maria
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-03-05
- Volume
- 22
- Issue
- 5
- Pages
- 2639
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7961600
- OpenAlex
- W3133763745
- Cited by
- 189
- References
- 120
- Citations by year
- 2026: 27 · 2025: 33 · 2024: 39 · 2023: 44 · 2022: 37 · 2021: 9
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Rehabilitation › Exercise and Physiological Responses
- Keywords
- adipokines, myokines, hepatokines, crosstalk, hormone signaling, paracrine signaling, autocrine signaling, type 2 diabetes, obesity, metabolic syndrome, cardiovascular disease, myostatin, FGF21, inflammatory cytokines, resistin, chemerin, TNF-α, interleukin-1, fatty acid beta-oxidation, lipogenesis, therapeutic target
- MeSH terms
- Animals, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Obesity, Cytokines, Metabolic Syndrome, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review